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ABSTRACT 
Purpose: One of the predominant computed tomography (CT) dosimetry estimation programs, 
ImPACT, was not designed to estimate organ absorbed dose or effective dose for modern tube 
current modulated-CT (TCM-CT). ImPACT also only estimates organ doses for a standard adult 
hermaphrodite mathematical phantom, not for a specific patient. Two methods for calculating 
size specific TCM-CT organ absorbed dose and non-size dependent TCM-CT effective dose 
were developed and compared with conventional dose estimation methods. 
Methods: A sample of 48 TCM-CT urogram procedures was obtained. Patient specific dose was 
calculated for each data set by two methods. The first method was a summation of slice by slice 
(localized) parameter estimates. Parameters from each slice were input separately in ImPACT 
the output organ dose,   , and effective dose,   , were recorded. The organ dose was then 
multiplied by a size dependent conversion factor to acquire a size specific organ dose. Then the 
size specific organ doses and the slice effective doses were summed over all slices to calculate 
the total organ doses and effective dose. The second method estimated doses based on global 
scan parameters. The effective dose was calculated with global average scan parameters in 
ImPACT. The output organ doses were multiplied by the average size dependent conversion 
factor to get the size dependent organ doses. The organ doses were then compared with a non-
size adjusted method and the effective doses with a conventional k-factor method. 
Results: The two size dependent organ dose estimation methods fell within acceptable difference 
criteria when compared directly with each other. The three effective dose estimation methods 
also fell within the criteria.  
Conclusion: These results suggested that using the global parameter method is acceptable for 
calculating effective dose and patient specific organ doses for TCM-CT urogram protocols.
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CHAPTER 1. INTRODUCTION 
Computed tomography (CT) has become an important medical tool since its inception 
over 40 years ago. Although CT only accounts for 17% of total radiology procedures, it 
contributes almost 50% to radiological collective dose in the United States (NCRP, 2009). This 
contribution has increased due to a 10 – 15% per year growth in CT usage from the early 1990’s 
to the mid 2000’s (NCRP, 2009). The diagnostic benefits of CT are well known but recent public 
awareness of possible side effects of ionizing radiation from CT has led to safety campaigns 
which include tracking radiation doses from CT procedures. So, accurate estimation of patient 
dose is important for physicians to appropriately weigh benefits and risks to patients and to 
comply with current and future regulations. 
1.1 Brief History of Computed Tomography 
CT is an imaging technology consisting of a patient table surrounded by a gantry, 
consisting of an x-ray tube generator and a detector array. A 3-dimensional representation of the 
interior of a patient is generated with multiple x-ray projections as the gantry rotates around the 
patient. The 3-D image is visualized as 2-D image slices, tomograms, for the purpose of medical 
diagnostics. The first patient CT scan was in October 1971 by Godfrey Hounsfield and his team 
at EMI Central Research Laboratories in London (ImPACT Scan Working Group, 2013). The 
first clinical scan was an 80 x 80 matrix image, seen in Figure 1-1, of a patient’s frontal lobe and 
took five minutes to scan and five minutes of computing time to produce the image (ImPACT 
Scan Working Group, 2013). CT technology developed rapidly in the 1970s and by 1979 
approximately 1000 CT scanners were used in hospitals worldwide (ImPACT Scan Working 
Group, 2013).  
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Figure 1-1: First clinical CT image (ImPACT Scan Working Group, 2013) 
1.1.1 Axial CT 
CT acquisition times decreased and spatial resolution increased throughout the 1980s but 
all scanners up to the 1990’s were axial scanners. Axial CT scanners maintain a stationary table 
while the gantry completes one 360 degree rotation. The table then moves the distance of the 
beam width before stopping and conducting another 360 degree gantry rotation. This is repeated 
until the entire scan length has been completed, as seen in Figure 1-2. The main disadvantage of 
axial scanners is the slow acquisition time. No matter how fast the x-ray tube and detector 
rotates, there is a time delay for the table movement time. This creates a higher probability of 
patient movement during the scan, increasing the probability of movement artifacts. 
 
Figure 1-2: Concept for axial CT scanner 
Beam Width 
Table 
Movement 
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1.1.1 Helical and Multi-Slice CT 
The 1990s saw two advances in CT technology, helical and multi-slice scanners. A 
helical scanner does not stop the gantry rotation for the table movement. The gantry rotates at a 
continuous rate while the table moves throughout the scan length. This creates a helical pattern 
of the x-ray scan, as seen in Figure 1-3. Helical scanners have faster acquisition times, allowing 
for more control of the CT dose. The rate of table movement versus gantry rotation is 
represented by, pitch, where, 
       
      
  
  
Equation 1-1 
In Equation 1-1, nT is the collimated beam width and        is the table feed distance per gantry 
rotation (Bushberg, Seibert, Leidholdt, Jr., & Boone, 2012). 
 
 
Figure 1-3: Concept of helical CT scanner 
The second important improvement to CT in the 1990s was the development of multiple 
detector array CT (MDCT). Before MDCT, the CT x-ray beam was detected by a single row of 
detectors which defined a slice. So, slice thickness was only a function of the beam width. 
MDCT detector arrays have several rows of smaller detectors, ~ 1 mm each, aligned along the 
same detector region. This allowed scan slices to be defined based on the configuration of the 
Detector Array 
Thickness (nT) 
Feed Distance per 
Rotation (      ) 
Table 
Movement 
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detector, not the beam width (Bushberg, Seibert, Leidholdt, Jr., & Boone, 2012). So, several 
slices can be acquired simultaneously. Figure 1-4 is a diagram from AAPM Report 96 that 
compares a MDCT detector array to a single-slice detector configuration. 
 
Figure 1-4: MDCT array 
The single-detector row CT (SDCT) system on the left has one detector element 
along the longitudinal axis and many (approx. 900) elements on the arc around the 
patient. The width of the detector (relative to the center of the gantry) is 20 mm, 
although the maximum beam width is only 10 mm. Thus the detector is wider 
than the x-ray beam. The multiple-detector-row CT (MDCT) system on the right 
has 16 1.25-mm detector elements along the longitudinal axis for each of the 
approximately 900 positions around the patient. The width of the detector is also 
20 mm at isocenter. Four data channels allow the acquisition of four simultaneous 
slices, of either 1.25, 2.5, 3.75, or 5 mm width (AAPM Task Group 23, 2008). 
1.1.2 Tube Current Modulation 
The final development in CT technology pertinent to this project, developed extensively 
in the early 2000s, is tube current modulated-CT (TCM-CT). Computed tomography prior to 
TCM-CT used a constant tube current throughout the scan length. The key problem with these 
constant current machines is that they produce more dose to the patient than necessary since 
areas in the scan region with low attenuation are irradiated with the same tube current value as 
areas with high attenuation. TCM-CT addressed this problem by varying tube current throughout 
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a scan to account for patient attenuation while maintaining acceptable image quality 
(Khatonabadi, et al., 2013).  
Prior to a TCM-CT procedure, the scanner conducts a low dose non-rotating topogram 
over the scan length to calculate the appropriate tube currents to apply across each region of the 
body. The variations are then applied throughout the rotation (x-y) plane and the length of the 
scan (z direction) based on the topogram calculations. Figure 1-5, demonstrates how the tube 
current fluctuates during the scan directions.  
 
Figure 1-5: Tube current modulation 
(a) An example of a chest exam’s TCM profile, illustrating the variation of the 
tube current along the patient’s z-axis and within the axial plane. (b) An example 
of an abdomen/pelvis exam’s TCM profile, illustrating three different attenuation 
regions: lungs, abdomen, and pelvis. The global average tube current, dashed line 
(Khatonabadi, et al., 2013). 
1.2 Computed Tomography Dosimetry 
1.2.1 CT Dosimetry Basics 
In order to estimate possible deterministic and stochastic side effects from CT radiation, 
we must first know the dose, energy (J) imparted per unit mass (kg), received by the patient. The  
absorbed dose, D(x), is defined with a narrow beam geometry, at depth x with, 
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 ( )   ∫  ( )    ( )     
    
    
  
Equation 1-2 
where  is the energy spectrum of the beam and   is the effective attenuation coefficient for a 
particular average energy (Bushberg, Seibert, Leidholdt, Jr., & Boone, 2012). ( ) is a 
description of the relative photon fluence at particular energies across the x-ray beam spectrum. 
The two key factors this relates to in radiography are the peak x-ray tube energy, kVp, and the x-
ray tube current, mA, which multiplied by the exposure time gives mAs. An increase in kVp 
typically corresponds to an increase proportional to the square of the dose and an increase in 
mAs is directly proportional to an increase in dose. This proportionality makes dose estimation 
calculations fairly straight forward in radiography and fluoroscopy where x-ray beams are 
approximately mono-directional but dose estimation for CT imaging is not as trivial.  
Several factors complicate CT dose estimations. First, the gantry rotates; so instead of a 
dose-depth relation that is very significant with a mono-directional beam, CT doses are more 
evenly distributed within a patient. Second, Equation 1-2 does not include scattered radiation 
which can deposit in a region outside the x axis. Also, since dose is the energy imparted per mass 
(J/kg), CT system pitch becomes important in dose calculations since beam widths and scattered 
radiation may overlap and have an additive effect over that overlapped region. A slower table 
speed has a smaller pitch corresponding to higher dose to the patient since the same region of the 
patient will have a higher probability of being exposed from multiple rotations. A higher pitch 
has the opposite effect. Finally, unlike radiographic imaging, where the exposure time is over a 
single region, the beam in helical CT scanning is constantly changing the exposed region of the 
body. 
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1.2.2 CT Dose Index and Dose Length Product 
Obviously, with different beam widths, CT pitches, and scan lengths, defining a single 
CT dose parameter for comparison and testing is important. Although defined originally as an 
index, not as a dosimetry metric, the computed tomography dose index (CTDI) has been 
modified to be the current worldwide standard CT dose estimator, with mixed results (Bushberg, 
Seibert, Leidholdt, Jr., & Boone, 2012). The CTDI concept begins with        .         is the 
dose measured with a 100 mm pencil chamber inserted in one of two locations in a 32 cm body 
or 16 cm head polymethylmethacrylate (PMMA) phantom (Bushberg, Seibert, Leidholdt, Jr., & 
Boone, 2012). The dose is measured over one axial rotation of the gantry with no table 
translation,  
        
 
  
 ∫  ( )  
     
     
  Equation 1-3 
where nT is the collimated beam width in the z direction, n is the number of detectors in the z 
direction and T is the thickness of each detector. D(z) is the dose distribution along the z axis, 
measured in units of gray (Gy). The detector measurement must be corrected for the fact that the 
CT beam thickness does not necessarily correspond to the 100 mm pencil chamber length 
(Bushberg, Seibert, Leidholdt, Jr., & Boone, 2012). The two acceptable locations for the detector 
in the phantoms are holes in the center and the edge (1 cm from exterior), as seen in Figure 1-6. 
This implies four types of        :                and              for both head (16 cm) and 
body (32 cm) phantoms.  
The         only indicates the average dose over a 100 mm section at a specified depth 
of a phantom, so a weighted CTDI was developed,      , to give a better indicator of an  
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average dose throughout the phantom,  
      
 
 
               
 
 
             Equation 1-4 
      is a strong indicator of scanner specific radiation output based on kVp and mAs (AAPM 
Task Group 23, 2008). Yet, this only gives an average dose throughout a 100 mm section of the 
phantom for an axial rotation.  
 
Figure 1-6: PMMA phantom for CTDI measurements 
The phantom is either 32 cm or 16 cm in diameter depending on the use. The 
pencil chamber is placed in the center or peripheral hole for measurements with a 
PMMA plug in the empty hole. (AAPM Task Group 204, 2011). 
 
To convert this to an average dose in the same region for a helical CT scanner, a 
volumetric CTDI is defined as,  
        
     
     
  Equation 1-5 
        is the current standard dose metric for CT dosimetry. It is particularly useful for 
comparing CT dose between different CT scanners for similar protocols or to compare different 
scans with the same systems with changes in the CT parameters or protocols. Table 1-1, taken 
from ACR-AAPM Resolution 47, lists CTDI guidelines for various CT protocols (ACR-AAPM, 
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2013). Achievable Dose (AD) refers to the median         for the particular scan protocol. The 
Diagnostic Reference Level (DRL) refers to a threshold which, if exceeded, a physicist should 
inspect the protocol settings to ensure the CT scanner does not deliver more dose than necessary. 
Table 1-1: Diagnostic reference levels and achievable doses for adult and pediatric CT (ACR-
AAPM, 2013) 
 
CTDI Phantom 
Diameter (cm) 
DRL (mGy) AD (mGy) 
Adult head 16 75 57 
Adult abdomen-pelvis 32 25 17 
Adult Chest 32 21 14 
Pediatric 5 year old head 16 40 31 
Pediatric 5 year old abdomen-pelvis 16 20 14 
 
Despite its usefulness in comparing CT scanners and different protocols, there are several 
problems with using         as dose metric.         was developed for a constant current CT 
machine to be a dose indicator for a constant output throughout a scan. Yet, most modern CT 
scanners are TCM machines. So, throughout a single CT rotation, the tube current is changing to 
take into account the attenuation of the particular region being scanned. The tube current also 
changes throughout the length of the scan in TCM-CT. Therefore, the         for any scan can 
be different throughout the length of that scan; each rotation can have a different         under 
the definition we use here. To account for complications of dose estimation due to TCM-CT 
current fluctuation, the International Electrotechnical Commission (IEC) redefined         as 
based on the average scan current (Lee, et al., 2012). So, instead of using the actual machine 
constant current as was performed before TCM-CT, the average current, as seen in the dashed 
line in Figure 1-5, is used to calculate        .  
Another problem with using         as a dose metric is that it is not a good indicator of 
total absorbed dose by the patient since it does not take into account the length of the scan or the 
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region scanned. To take the scan length into account we must define a new metric, dose length 
product (DLP) was introduced as, 
    (      )           (   )    (  )  Equation 1-6 
where L is the scan length. While DLP is a better indicator of total energy absorbed in a patient, 
it is not a good metric to base patient risk. DLP does not indicate which anatomical region of a 
patient dose is deposited. So, two separate CT scans, one of a patient’s head and another of the 
same patient’s pelvis, may have the same DLP value but those two values will have completely 
different implications for risk to the patient due to radiation dose. Therefore, a different dose 
metric should be used if we want to know more information about the location of deposited dose. 
1.2.3 Organ and Effective Dose  
If we wish to estimate dose in more localized regions and understand the biological 
effects and risks of that dose, then organ dose and effective dose are better metrics than         
and DLP for patient dosimetry. As with         and DLP, we begin our description of organ and 
effective dose with absorbed dose. Recall that absorbed dose is only a measure of energy 
deposited in tissue. Absorbed dose does not take into account that different types of radiation, 
e.g. a, β, γ, and x-ray, have different biological effects on tissue. So, to account for those 
effects, we multiply the absorbed dose by a radiation weighting factor,   , to find the equivalent 
dose, 
  (  )   (  )      Equation 1-7 
where    is in units of sieverts (Sv). The weighting factor,    for x-rays is 1 Sv/Gy so the 
absorbed dose and equivalent dose have equal values with different units in CT dosimetry.  
We can carry the dose concept further with the knowledge that different organs have 
vastly different radiosensitivity to stochastic effects. So, we introduce a tissue weighting factor, 
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  , which weights each organ with a ratio of total characteristic risk. This ranges from 0.01 for 
less radiosensitive organs like the brain to 0.12 for more radiosensitive organs like bone marrow. 
International Commission on Radiological Protection (ICRP) Report 103 list weighting factors 
for 14 organs and gives a weighting factor value of the remainder organs, i.e. those not listed in 
that list of 14 organs. The sum of the 14 organ plus remainder weighting factors is one. These 
weighting factors help us introduce the concept of the effective dose. Effective dose is the key 
radiation dosimetry metric used by the ICRP to estimate stochastic radiation risk. It is defined, 
 (  )  ∑       
 
  Equation 1-8 
where the summation is over all ICRP 103 organ types. An important note to make about 
effective dose is that, since    factors are calculated from a large population, they are only 
indicative of a dose to a generic “standard man” patient. Thus, effective doses are indicative of 
population risk, not an individual’s risk of stochastic effects.  
Notice that equivalent dose and effective dose have the same units even though they have 
vastly different meanings. A 25 mSv liver dose is not the same as a 25 mSv effective dose. The 
specific liver dose is better for estimating possible deterministic effects but the effective dose is 
used only for estimating stochastic risk in a population. Although, technically, organ doses 
should be reported in equivalent dose units, Sv, we use absorbed dose, Gy, throughout this thesis 
to avoid confusion. Again, this has no real effect on the values since 1 Gy   1 Sv for x-rays. We 
also reiterate that, while organ dose is a patient specific metric depending on the variation of 
organ size in a particular patient, effective dose is defined for the average patient of a population. 
So, effective dose is not affected by variations of individual patients.  
The most accurate way to estimate organ and effective dose in CT is by using Monte 
Carlo simulation methods based on the specific scan parameters (Bushberg, Seibert, Leidholdt, 
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Jr., & Boone, 2012). Monte Carlo programs simulate photon absorption probabilities in various 
trajectories in a voxelized mathematical phantom. These programs compute the organ dose based 
on the anatomical region where the photon energy was deposited. This can be programmed for 
specific patient parameters, e.g., patient and organ sizes, to provide a very accurate model. 
Unfortunately, using Monte Carlo for each patient is not feasible due to the required computer 
power and computation time. Consequently, dose tables and commercial CT dosimetry packages 
were created for computing organ and effective dose based on previously conducted Monte 
Carlo outputs for various parameters.  
One such table is widely used to estimate effective dose based on the machine DLP 
output and specific scan region. AAPM Report 96 provides conversion factors, k-factors, to 
convert DLP to effective dose for specific CT exam types (AAPM Task Group 23, 2008). These 
coefficients were calculated based on comparing various Monte Carlo studies (AAPM Task 
Group 23, 2008). To calculate effective dose, E, from the reported DLP, the k-factor is selected 
from Table 1-2. Selecting the appropriate patient age and exam type provides the k-factor.  
Table 1-2: k-factor table (AAPM Task Group 23, 2008) 
Region of Body 
  (             ) 
0 year old 1 year old 5 year old 10 year old Adult 
Head & neck 0.013 0.0065 0.0057 0.0042 0.0031 
Head 0.011 0.0067 0.0040 0.0032 0.0021 
Neck 0.017 0.012 0.011 0.0079 0.0059 
Chest 0.039 0.026 0.018 0.013 0.014 
Abdomen/Pelvis 0.049 0.030 0.020 0.015 0.015 
Trunk 0.044 0.028 0.019 0.014 0.015 
 
Effective dose is then calculated with 
                   (   )     (      )    (             ). Equation 1-9 
Effective dose calculations using this method are fairly consistent, with deviations from the mean 
less than 15% (AAPM Task Group 23, 2008). The k-factor method does not, however, calculate 
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effective dose for scans that deviate from the typical regional scans in the table nor does the k-
factor method provide organ dose estimates. A more robust method to calculate effective dose 
and organ dose for specific scan parameters is to use software with datasets based on previously 
run Monte Carlo models, such as ImPACT. 
1.2.4 ImPACT Dosimetry Software 
The National Radiological Protection Board (NRPB), a public authority in the UK, 
conducted a Monte Carlo simulation survey in 1989 of x-ray spectra in a standard adult 
hermaphrodite mathematical phantom in CT (ImPACT Scan Working Group, 2013). A program 
was developed by the group, CTDOSE, using 23 data sets, NRPB SR-250, for the scanners 
available at the time. The SR-250 data provides normalized organ doses for various CT scanners 
of the mathematical phantom shown in Figure 1-7.  
 
Figure 1-7: NRPB mathematical phantom 
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The CTDOSE program calculated organ doses and effective dose based on CT 
parameters (ImPACT Scan Working Group, 2013). The main drawback to using these data sets 
is that they were only updated up to 1993 which only included scanners using axial scanning and 
non-angled gantries. They are vastly different from modern helical angled gantry machines. So, 
the NRPB developed a protocol to match modern scanners with the old NRPB data sets. These 
new downloadable datasets can be purchased through the NRPB and used with the free software, 
ImPACT CT Patient Dosimetry Calculator, available on their website (ImPACT Scan Working 
Group, 2013). The user inputs the machine manufacturer and model, tube current, beam energy, 
pitch, scan length, and the anatomical scan region shown in Figure 1-8. The program outputs 
scan dosimetry estimates: Volumetric CT Dose Index (       ), Dose Length Product (DLP), 
organ absorbed doses and effective dose shown in Figure 1-9. 
 
Figure 1-8: ImPACT CT patient dosimetry calculator input parameters 
The ImPACT spreadsheet is limited in its scope, though. The two major issues are that it 
does not take into account TCM or patient size parameters. The instructions published on the 
ImPACT webpage state that for TCM-CT the updated IEC definition of         should be used 
when calculating doses (ImPACT Scan Working Group, 2013). In other words, use the standard 
Scanner Model: Acquisition Parameters:
Manufacturer: Tube current 159 mA
Scanner: Rotation time 0.5 s
kV: Spiral pitch 0.828
Scan Region: mAs / Rotation 79.5 mAs
Data Set MCSET20 Effective mAs 96.01449 mAs
Current Data MCSET20       mm
Scan range Rel. CTDI 0.83766 0.84 at selected collimation
Start Position 12 cm CTDI (air) 38.367 38.4 mGy/100mAs
End Position 45 cm CTDI (soft tissue) 41.1 mGy/100mAs
nCTDIw 11.9637 12.0 mGy/100mAs
Organ weighting scheme
CTDIw 9.5 mGy
CTDIv ol 11.5 mGy
DLP 379 mGy.cm
ImPACT CT Patient Dosimetry Calculator
Version 1.0.4 27/05/2011
Collimation
Update Data Set
Look upGet From Phantom 
Diagram
Look up
Look up
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inputs as if the machine was not TCM and use the average scan current. Yet, this leads to the 
possibility of dose underestimation for high attenuation regions and dose overestimation for low 
attenuation regions since tube current is proportional to dose and organ absorbed dose is highly 
dependent on the scan location. Unfortunately, the ImPACT instructions do not cite a reference 
for justification of using the average current for TCM-CT.  
 
Figure 1-9: ImPACT spreadsheet output data 
Another major limitation of the ImPACT spreadsheet is that it does not take into account 
size variations from the standard mathematical phantom from which the NRPB data sets are 
based. This inability to estimate size specific dose is not necessarily a problem for effective dose 
estimates, since effective dose is only valid for a population average size. Yet, organ doses vary 
widely for deviations from the ImPACT phantom size. Therefore, we should make adjustments 
to the ImPACT organ doses to use them for dosimetry purposes.  
CTDIw 9.5 mGy
CTDIv ol 11.5 mGy
DLP 379 mGy.cm
Organ wT HT (mGy) wT.HT HT (mGy)
Gonads 0.08 5.9 0.47 Adrenals 14
Bone Marrow 0.12 5.4 0.65 Small Intestine 15
Colon 0.12 12 1.4 Kidney 19
Lung 0.12 3.2 0.38 Pancreas 14
Stomach 0.12 17 2 Spleen 15
Bladder 0.04 2.9 0.12 Thymus 0.5
Breast 0.12 0.64 0.077 Uterus / Prostate (Bladder) 7.5
Liver 0.04 15 0.61 Muscle 4.9
Oesophagus (Thymus) 0.04 0.5 0.02 Gall Bladder 17
Thyroid 0.04 0.055 0.0022 Heart 4
Skin 0.01 3.8 0.038 ET region (Thyroid) 0.055
Bone Surface 0.01 7.6 0.076 Lymph nodes (Muscle) 4.9
Brain 0.01 0.0019 0.000019 Oral mucosa (Brain) 0.0019
Salivary Glands (Brain) 0.01 0.0019 0.000019 HT (mGy)
Remainder 0.12 8.9 1.1 Eye lenses 0.00058
Not Applicable 0 0 0 Testes 0.2
Total Effective Dose (mSv) 6.90 Ovaries 12
Uterus 12
Prostate 2.9
Remainder Organs
Other organs of interest
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1.2.5 Size Dependent Dose 
Although effective dose is not patient or size specific, one can, however, estimate organ 
dose for a particular patient based on size. First, consider identical CT scans of two different 
cylindrical phantoms; one is twice as thick as the other with the same length. Assuming the same 
CT settings, i.e. mAs and kVp, for both scans, the smaller phantom will receive more absorbed 
dose than the larger phantom. At first glance, one could assume the smaller phantom would 
absorb less dose because it has less material, thus less probability of energy attenuation in the 
phantom volume. Yet, even though the larger phantom may absorbed more energy, that energy is 
spread out over a larger volume and mass. Therefore, the larger mass actually contributes to a 
smaller absorbed dose for the larger phantom. 
AAPM Report Number 204 (AAPM 204), Size-Specific Dose Estimates (SSDE) in 
Pediatric and Adult Body CT Examinations, was developed to account for size specific dose 
variations. In particular, AAPM 204 offers a modification to the industry standard CT dose 
metric by converting         to a size specific dose estimate (SSDE) based on an effective 
diameter conversion factor (EDCF). AAPM 204 is based on four size dependent CT dosimetry 
studies, each using different methods and phantoms. Two of the groups used physical phantoms, 
CT scanners and measurements, while two groups used Monte Carlo methods.  
McCollough et al. used tissue-equivalent anthropomorphic torso phantoms ranging from 
newborn to large adult sizes (AAPM Task Group 204). They used a 0.6 cc ion chamber and 
methods similar to measuring        to find the average dose throughout each phantom with 
different CT scanner models and different abdominal protocols. The measured values were 
divided by the scan         to calculate the EDCF based on patient size (AAPM Task Group 
204, 2011). Toth and Strauss used similar methods to McCollough et al. but with three PMMA 
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cylindrical phantoms (AAPM Task Group 204, 2011). They used regression models to link 
patient lateral size to EDCF factors. 
Turner et al. conducted a Monte Carlo analysis that studied the organ doses based on 
patient sizes with a Monte Carlo code (AAPM Task Group 204, 2011). They used eight 
voxelized patient models to represent patient sizes from infants to large adults (AAPM Task 
Group 204, 2011). They found a strong relationship between organ dose and patient size for 
organs fully irradiated by the CT-beam with less size-dependence on organ dose for organs that 
were partially or not directly irradiated by the beam (Turner, et al., 2011).  
The last group, Zhou and Boone at UC Davis, used basic cylindrical phantoms with a 
Monte Carlo code to calculate dose in infinitely long cylinders of different materials and 
thicknesses (AAPM Task Group 204, 2011). This study allowed for greater user analysis of the 
size dependence for specific x-ray spectrum and material. They normalized the data to calculate 
        for standard 16 and 32 cm PMAA phantoms based on the specific protocol used. 
AAPM task group 204 used these four studies to develop a standard method for scanner 
independent size dependent dose estimations. The method provides a single EDCF based on the 
reference         phantom, 16 cm or 32 cm, and the effective diameter of the patient. The 
EDCF is based on a measured diameter or cross-sectional area of the phantom or the patient, 
which can be used to find the effective diameter. In order to standardize the patient size 
measurement, AAPM 204, provides a simple method to measure patient size. The effective 
diameter of a patient is merely the equivalent diameter of cross-sectional cylinder (circle) to the 
cross-sectional area of the patient as in Figure 1-10. Table 1-3 provides the EDCF values from 
AAPM Report 204 based on the calculated effective diameter. 
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Figure 1-10: Effective diameter 
The effective diameter of the anatomical, non-circular, region is the diameter 
which would correspond to a circle of equal area (AAPM Task Group 204, 2011). 
 
Table 1-3: Effective diameter EDCF table (32 cm phantom) (AAPM Task Group 204, 2011) 
Effective 
Diameter 
(cm) 
EDCF 
8 2.76 
10 2.57 
12 2.38 
14 2.22 
16 2.06 
18 1.91 
20 1.78 
22 1.65 
24 1.53 
26 1.43 
28 1.32 
30 1.23 
32 1.14 
34 1.06 
36 0.99 
38 0.92 
40 0.85 
42 0.79 
44 0.74 
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To convert the         to an SSDE the following equation is presented in AAPM 204,  
                      Equation 1-10 
So, to calculate the effective diameter, the cross-sectional area of the patient is estimated by 
measuring the lateral and AP dimensions of the patient and calculating the effective diameter by, 
                   (  )   √  (  )     (  )  Equation 1-11 
where   (  )     (  ) also represents the area of a rectangle that the patient/phantom cross 
section is inscribed. We then use the reference phantom size and the patient effective diameter to 
look up the EDCF in AAPM 204. Equation 1-10 then gives us the SSDE. The AAPM 204 
method is not without its limitations, though. A patient does not have one effective diameter; the 
scanners used in the studies were constant current CT, not TCM-CT scanners. Also, AAPM 204 
does not extend SSDE to organ doses as Turner et al did.  
1.2.6 Dose Regulation and Reporting 
Two of the largest states in the United States currently have a mandate for recording CT 
dose in patient records. Although slightly different in scope and enforcement, California bill SB 
1237 and Texas Administrative Code 289.227 both mandate that        , DLP, or “dose unit 
recognized by the AAPM” be recorded in patient records. SB 1237 also mandates CT dose 
thresholds. A hospital or clinic must report to the California Department of Public Health (DPH) 
any of the following CT examinations over the wrong body region that exceed 50 mSv effective 
dose, 500 mSv organ dose, or 50 mSv skin dose (AAPM, 2011). 
The Joint Commission, a non-profit organization that accredits hospitals throughout the 
U.S., responded to those state laws by modifying its rules to reflect Ca SB 1237. This would 
mandate all medical facilities accredited with the Joint Commission to track        , DLP, or 
“dose unit recognized by the AAPM” in patient records. Unfortunately, neither SB 1237 nor the 
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Joint Commission define what “dose unit recognized by the AAPM” actually means. The AAPM 
and American College of Radiology actually recommends using SSDE or, for special 
circumstances, performing an individualized dose assessment instead of using         or DLP 
(ACR-AAPM, 2013). The initial dual stage implementation of those new Joint Commission 
Environment of Care (EC) standards was 1 July 2014 but was recently postponed to 2015 
partially due to the ambiguity in the dose tracking requirements (The Joint Commission, 2013). 
These mandates are not difficult in practice since, unlike organ and effective dose, 
        and DLP are printed by the CT machine after each scan and require no calculations. Yet, 
SB 1237 also mandates any organ dose above 500 mSv and any effective dose above 50 mSv be 
reported to a state review board. So, although not required for patient records, estimating organ 
doses and effective doses are required when a physicist believes these dose thresholds may have 
been exceeded. The key reason for this requirement is that        and DLP for multiple scans 
on the same patient are not necessarily indicative of characteristic or deterministic health risks to 
the patient if those scans are not over the same anatomical regions. In a presentation at the 
AAPM 2011 Summit on CT Dose, Dr. Michael McNitt-Gray, UCLA, states that the most useful 
metric to estimate patient radiation risk for CT is the absorbed dose to individual organs of 
interest and suggest that future regulations will require tracking individualized organ doses 
(McNitt-Gray, 2011). Of course, as discussed so far, calculating organ doses is not necessarily 
trivial due to variable patient sizes and TCM-CT.  
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 HYPOTHESIS AND SPECIFIC AIMS CHAPTER 2.
One of the predominant programs for estimating CT dose, ImPACT, is based on National 
Radiological Protection Board (NRPB) data that assumes a standard adult hermaphrodite 
mathematical phantom and a constant machine current throughout a scan. Unfortunately, few 
patients match standard adult phantom parameters and most modern CT machines use a variable 
tube current throughout a scan, therefore the ImPACT program does not calculate a patient 
specific organ or effective dose for TCM- CT. These complications with organ and effective 
dose assessment may add a larger work-load for medical physicists when new mandates from the 
Joint Commission come into effect. So, any methods that reduce the time involved in estimating 
patient dose while maintaining an acceptable level of error will be helpful. We compared two 
methods of ImPACT-based size-specific organ dose estimation with the conventional non-size 
specific organ dose estimation. We also compared two methods of generic patient effective dose 
estimation using the ImPACT program with the conventional k-factor method. 
2.1 Organ Dose Estimates 
The first organ dose method calculated the organ absorbed dose for each CT slice with 
ImPACT independently based on the slice tube current. A size specific dose estimate (SSDE) 
conversion factor based on AAPM Report 204 was applied to each slice dose and all slices were 
summed to provide organ dose estimates. Throughout this thesis this method is defined as the 
size slice organ dose (SSOD) method. The second method calculated the organ dose with one 
calculation step based on the average scan tube current and an average patient EDCF. This 
method is defined throughout this thesis as the size average organ dose (SAOD) method. Both 
models are then compared with a conventional organ dose estimation method, where we used the 
average CT parameters in ImPACT without adjusting for the size of the patient. We refer to this 
more conventional model as the Non-size Average Organ Dose (NAOD) method. 
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2.2 Effective Dose Estimates 
The first method is similar to the slice by slice organ dose estimation method. We find 
the contribution to the effective dose in ImPACT from each slice then sum those slice 
contributions to find the effective dose. We do not adjust for patient size in these calculations. 
We define this method as the Slice Effective Dose (SED) method. The second method uses the 
program recommendation of the ImPACT working group; we merely input the average scan 
parameters and find the ImPACT effective dose. We define this as the Average Effective Dose 
(AED) method. We then compare both models with the more conventional k-factor method.  
2.3 Hypothesis 
The hypothesis is that the differences between the Size Slice Organ Dose (SSOD) and 
Size Average Organ Dose (SAOD) methods will be within acceptable limits to justify using the 
more trivial SAOD method to estimate TCM-CT patient specific organ doses. Also, differences 
between the Slice Effective Dose (SED), Average Effective Dose (AED), and k-factor methods 
will be within acceptable limits to justify using the more trivial AED or k-factor method to 
estimate TCM-CT effective doses.  
2.4 Specific Aims 
2.4.1 Specific Aim 1 
Estimate the doses with the slice by slice tube current method; estimate organ dose with 
the SSOD method and effective dose with the SED method. 
2.4.2 Specific Aim 2 
Estimate the doses with the average tube current method; estimate organ dose with the 
SAOD method and the effective dose with the AED method. 
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2.4.3 Specific Aim 3 
Compare the SSOD, SAOD, and NAOD methods and compare the SED, AED, and k-
factor methods using appropriate statistical tests. Develop criteria for limits of clinical 
acceptability and determine which models are acceptable for clinical use. 
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 METHODS AND MATERIALS CHAPTER 3.
3.1 Data Collection 
Twenty-four multiphase CT procedures (48 scans) using a Urogram protocol performed 
at Brooke Army Medical Center (BAMC) from 2007-2011 were reviewed for this study. The 
Urogram protocol scan regions range from the mid thorax to the pelvis (Abdominal-pelvis). 
Scans with lengths under 25 cm were deleted to ensure all assessed organs were at least partially 
exposed with the primary CT fan beam. Each scan contains two sources of data, the scan dose 
report (one per scan) and the individual slice images (80-180 slices per scan). The dose report 
includes the patient age, sex, beam energy, slice thickness, pitch, anatomical start and ending 
locations, and average         and DLP. The slice images include the slice tube current (mA), 
the field of view (FOV) and anatomical location of the slice. The necessary data from these 
sources was documented and image measurements were performed on a secure computer at 
BAMC. Only data without Personally Identifiable Information (PII) was transferred to a personal 
computer for processing. There is no way to track estimated doses to any particular patient, 
ensuring HIPAA compliance. All slice images taken from the BAMC facility for use in this 
thesis were purged of PII. BAMC Institutional Review Board (IRB) approval was completed 
when this project was initially initiated by Dr. Jonathon Tucker for a dosimetry comparison 
study. 
3.2 Dose Calculation Methods 
3.2.1 Historical and Conventional Methods 
The Non-size Average Organ Dose (NAOD) method was used as a conventional 
comparison for organ dose estimates. The average CT scan parameters were used in ImPACT 
and the program output includes the organ doses for a standard mathematical hermaphrodite 
adult phantom. No size adjustments are performed on these results. The conventional comparison 
 25 
 
method for effective dose is the k-factor method described in Section 1.2.3. The CT DLP output 
was multiplied by k-factors found in AAPM Report 96 (AAPM Task Group 23, 2008). 
3.2.2 Slice by Slice Method (Specific Aim 1) 
The body cross-sectional effective diameter for each slice was calculated using 
measurements from ImageJ image processing software. First, a pixel size was attributed to 
millimeters by defining the image area to the Field of View (FOV), under the “Set Scale” option 
in the “Analyze” tab. The slice effective area was then measured by drawing a box around the 
slice image in the AP and lateral directions, Figure 3-1. Effective diameter (    ) was calculated 
with Equation 3-1, 
     √         √     Equation 3-1 
where     is the area of the rectangle for which the slice image is inscribed. 
 
Figure 3-1: Image-J box area 
 26 
 
Dose calculations were performed with ImPACT. Input parameters included the machine 
manufacturer and model, channels used, slice thickness, anatomical start location, pitch, rotation 
time, scan length (one slice), energy (kVp) and tube current (mA). The slice thicknesses for all of 
our scans were 5mm. The only parameters that change in TCM-CT for each rotation are the 
current and the anatomical start and end locations. So, an Excel workbook was developed that 
uses the ImPACT base program to change those input parameters for each rotation. Our output 
data includes the organ dose and effective dose contribution from each slice as if it were an 
independent scan. The slice organ dose is listed as    and the slice effective dose as   , where j is 
the organ and i is the slice.  
The slice effective dose contributions are summed for all slices in a scan to find the SED 
estimate for that particular scan, 
    ∑   
 
 
  
Equation 3-2 
Finally, the Excel program looks up the conversion factor for a specific slice,      , and 
multiplies it by the organ doses delivered by that specific slice. These doses are summed over all 
the slices of the scan to give us the SSOD for each organ, j,  
      ∑   
 
 
  Equation 3-3 
3.2.3  Total Scan Method (Specific Aim 2) 
The total-scan methods to estimate organ dose is much less complex and time intensive 
than the slice by slice methods. An average body effective diameter is calculated by averaging 
three effective diameters along the scan length. This can be performed post-scan with images or 
pre-scan with a tape measure or a caliper. The appropriate EDCF is based on the average 
effective diameter. 
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For the SAOD estimation method, the average tube current along the z-direction was 
input in ImPACT. ImPACT provides non-size adjusted organ doses and our AED estimate. The 
ImPACT organ dose results were then multiplied by the averaged EDCF to get the SAOD for all 
organs. 
3.2.4 Statistical Analysis (Specific Aim 3) 
The two dose metrics, organ dose and effective dose, cannot be compared with each 
other. So, comparisons of the three organ dose estimate methods and comparisons of the three 
effective dose estimate methods were performed separately. All dose metrics were calculated 
from measurements taken on the same subject. Therefore, for the same subject, the three cannot 
be assumed to be independent. Accordingly, a Repeated Measures One-way Analysis of 
Variance (RM-ANOVA) model was used to test for equality of the three organ dose methods and 
the three effective dose methods, see Table 3-1. 
Table 3-1: RM-ANOVA tests hypotheses 
Repeated Measures One-Way ANOVA (RM-ANOVA) 
Dose Method Comparisons Null Alternative α 
Organ Dose    
SSOD 
(A) 
SAOD 
(B) 
NAOD 
(C) 
         Any violation of Null 0.05 
Effective Dose 
SED 
(D) 
AED 
(E) 
k-factor 
(F) 
         Any violation of Null 0.05 
 
RM-ANOVA is strongly dependent on two assumptions, namely, normality and 
sphericity. These assumptions must be validated before performing the RM-ANOVA test. The 
normality assumption for each data set was checked formally with a Chi-Square Goodness of Fit 
test, and graphically with a normal probability plot in Microsoft Excel. The sphericity 
assumption was tested by the SAS GLM Procedure when the RM-ANOVA was performed. 
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Upon violations of the sphericity assumption, SAS prints a Greenhouse-Geisser (G-G) correction 
factor to adjust the degrees of freedom. This correction adjusts the final p-value estimate on the F 
statistic. Results and further descriptions of the assumption tests are in Appendix A. 
Several pairwise comparisons of the population means were performed, using paired t-
tests, if the RM-ANOVA null hypotheses were rejected. For the organ dose estimates, the SSOD 
and SAOD methods were compared (i.e. µA versus µB), as were the SSOD and NAOD and 
methods (i.e. µA versus µC). SAOD was not compared to NAOD, since the difference between 
the two is merely the average EDCF from AAPM 204. For the effective dose estimates, pair-
wise comparisons of the SED, AED, and k-factor methods were made (i.e. µD versus µE, µD 
versus µF, and µE versus µF). 
For each comparison, two separate types of paired t-tests were performed, a conventional 
paired t-test using ordinary differences and a more unconventional paired t-test using relative 
differences. For example, the difference of organ dose methods SSOD (A) and SAOD (B), A – 
B, was used to test a hypothesis for µA - µB. The relative difference of organ dose methods 
SSOD (A) and SAOD (B) is defined as A* - B*, where 
    [(   )  ⁄ ] ⁄      
   [(   )  ⁄ ] ⁄  Equation 3-4  
This difference was used to test a hypothesis for µA* - µB*. Using both ordinary and relative 
differences provide more information and allow more flexibility when determining whether or 
not to reject null hypotheses. 
Two organ dose methods or two effective dose methods were declared clinically similar 
if the relative difference between the corresponding population means was less than 0.20 (20%) 
in magnitude. For example, in order for dose methods SSOD (A) and SAOD (B) to be clinically 
similar, -0.20 ≤ µA* - µB* ≤ 0.20. This is somewhat arbitrary but corresponds to Nuclear 
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Regulatory Commission mis-administrations levels in Nuclear Medicine. Also, 20% is the 
maximum deviation allowed for CTDI dose report values from measured values in the Joint 
Commission recommendations (The Joint Commission, 2013). A 20% deviation in dose 
estimation may seem high, but it means very little if the total dose is very small.  
In addition, two organ dose (effective dose) methods were declared clinically similar if 
the ordinary difference between the corresponding population means was less than 5 mGy (0.5 
mSv) in magnitude. For example, in order for organ dose methods SSOD (A) and SAOD (B) to 
be clinically similar, -5 mGy ≤ µA - µB ≤ 5 mGy, while effective dose methods SED (D) and 
AED (E) are clinically similar if -0.5 mSv ≤ µD - µE ≤ 0.5 mSv. As discussed in Section 1.2.6, 
SB 1237 listed maximum organ and effective dose limits over the wrong region of body as, 500 
mGy for organ dose and 50 mSv for effective dose. Also, the ACR-AAPM Resolution 47 
suggests that the DRL for adult abdomen-pelvis scans is 25 mGy (ACR-AAPM, 2013). The 
values 5 mGy and 0.5 mSv correspond to to 1% respectively.                                                        
There is a direct relationship between confidence intervals and hypothesis tests. The (1-
α)*100% confidence interval for, say, µA - µB consists of all λ values for which the null 
hypothesis H0 : µA - µB = λ (versus Ha: µA - µB ≠ λ with P(I)= α) is accepted. Therefore, the 
organ dose methods SSOD (A) and SAOD (B) would have been declared clinically similar 
(clinically dissimilar) with (1-α)*100% confidence if the entire interval of numbers [-5 mGy, 5 
mGy] had been contained in (had been outside of) the (1-α)*100% confidence interval for µA - 
µB . The effective dose methods SED (D) and AED (E) would have been declared clinically 
similar (clinically dissimilar) with (1-α)*100% confidence if the entire interval of numbers [-0.2, 
0.2 ] had been contained in (had been outside of) the (1-α)*100% confidence interval for µD* - 
µE* (see Table 3-2 and Table 3-3).  
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Table 3-2: Organ dose post-hoc paired t-tests 
Post-hoc Organ Dose t-tests (Overall α = 0.12 – Bonferroni adjustment) 
Performed for each        
Method Comparisons Difference Type CI Test α 
SSOD (A) NAOD (C) 
Absolute              0.03 
Relative         
    
    0.03 
SAOD (B) NAOD (C) 
Absolute              0.03 
Relative         
    
    0.03 
 
Table 3-3: Effective dose post-hoc paired t-tests 
Post-hoc Effective Dose t-tests (Overall α = 0.12 – Bonferroni adjustment) 
Method Comparisons Difference Type CI Test α 
SED (D) k-factor (F) 
Absolute              0.02 
Relative         
    
    0.02 
SED (D) AED (E) 
Absolute              0.02 
Relative         
    
    0.02 
AED (E) k-factor (F) 
Absolute              0.02 
Relative         
    
    0.02 
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 RESULTS AND DISCUSSION CHAPTER 4.
4.1 Organ Dose Summary 
4.1.1 Organ Dose ANOVA Tests 
Table 4-1 shows the results of the RM-ANOVA and sphericity assumption tests for each 
organ. The sphericity null hypothesis is rejected at a=0.05 for gonads, bone marrow, colon, 
bladder, breast, skin, bone surface, adrenals, small intestine, and uterus. For these organs the 
Greenhouse-Geisser (G-G) adjusted p-value is used for the RM-ANOVA. All other organs use 
the non-adjusted p-value. In either case, all the null hypotheses for the RM-ANOVA organ dose 
comparisons are rejected at a=0.05. The alternative hypothesis is accepted for each organ; the 
three estimate methods are not the same. 
Table 4-1: Organ dose RM-ANOVA tests results 
 
Organs 
Sphericity 
p-Value 
Sphericity 
Rejected? 
F-value 
Non-Adj 
p-Value 
G-G Adj 
p-Value 
Null 
Rejected? 
(α=0.05) 
1 Gonads <0.0001 Yes 156.36 <0.0001 <0.0001 Yes 
2 Bone Marrow <0.0001 Yes 413.68 <0.0001 <0.0001 Yes 
3 Colon <0.0001 Yes 314.72 <0.0001 <0.0001 Yes 
4 Lung 0.0559 No 40.96 <0.0001 <0.0001 Yes 
5 Stomach 0.2478 No 259.88 <0.0001 <0.0001 Yes 
6 Bladder <0.0001 Yes 243.71 <0.0001 <0.0001 Yes 
7 Breast <0.0001 Yes 16.68 <0.0001 <0.0001 Yes 
8 Liver 0.2200 No 175.64 <0.0001 <0.0001 Yes 
9 Skin <0.0001 Yes 418.28 <0.0001 <0.0001 Yes 
10 Bone Surface <0.0001 Yes 418.09 <0.0001 <0.0001 Yes 
11 Adrenals 0.0040 Yes 80.26 <0.0001 <0.0001 Yes 
12 Small Intestine <0.0001 Yes 250.37 <0.0001 <0.0001 Yes 
13 Kidney 0.0232 Yes 298.69 <0.0001 <0.0001 Yes 
14 Pancreas 0.1685 No 178.05 <0.0001 <0.0001 Yes 
15 Uterus <0.0001 Yes 244.88 <0.0001 <0.0001 Yes 
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4.1.2 Organ Dose Post-hoc t-tests 
The organ with each type of statistical test, absolute and relative, is listed with an 
experiment-wise alpha level at a=0.12. So, the individual pair-wise alpha level is a=0.03 due to 
the Bonferroni adjustment. There are two pair-wise comparisons, SSOD versus NAOD and 
SSOD versus SAOD, with absolute and relative tests for a total of four comparisons. The upper 
and lower bounds of the two sided 97% CI are also listed in Table 4-2.  
The absolute null hypothesis is rejected with four organs: bone marrow, lung, breast, and 
skin. This means that all other organ dose differences, besides the four listed above, are 
sufficiently large enough to exceed the absolute difference criteria range, -5 mGy ≤ µA - µB ≤ 5 
mGy. Also, the relative null hypothesis is not rejected for any organ except lung and breast since 
all other relative difference upper bounds are larger than 0.20. The lung upper and lower CI is 
0.18 and 0.08 and the breast upper and lower CI is 0.12 and 0.20 with p-values of 0.002 and 
0.0246 respectively. So, the difference between these two models is less than 20% for lung and 
breast but greater than 20% for all other organs. Also, under the definition listed in Section 3.2.4, 
the SSOD and the NAOD are only clinically similar for bone marrow, lung, breast and skin. The 
first pair-wise comparison is the SSOD method versus the NAOD method, summarized in Table 
4-2. Figure 4-1 and Figure 4-2 show the graphical representation of the pair-wise comparison. 
Table 4-2: SSOD versus NAOD pair-wise t-tests 
Organ 
Difference 
Type 
Clinically 
Similar 
Bound 
Confidence 
Intervals Max 
p-Value 
Reject 
Null? 
Clinically 
Similar? 
97% CL 
Gonads 
Absolute -5 & 5 6.10 8.80 >0.9999 No 
No 
Relative -0.20 & 0.20 0.39 0.47 >0.9999 No 
Bone 
Marrow 
Absolute -5 & 5 3.25 4.06 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.31 0.37 >0.9999 No 
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(Table 4-2 Continued) 
Organ 
Difference 
Type 
Clinically 
Similar 
Bound 
Confidence 
Intervals Max 
p-Value 
Reject 
Null? 
Clinically 
Similar? 
97% CL 
Colon 
Absolute -5 & 5 7.58 9.89 >0.9999 No 
No 
Relative -0.20 & 0.20 0.32 0.38 >0.9999 No 
Lung 
Absolute -5 & 5 0.40 1.50 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.08 0.18 0.0020 Yes 
Stomach 
Absolute -5 & 5 6.04 8.04 >0.9999 No 
No 
Relative -0.20 & 0.20 0.24 0.29 >0.9999 No 
Bladder 
Absolute -5 & 5 11.44 15.14 >0.9999 No 
No 
Relative -0.20 & 0.20 0.40 0.49 >0.9999 No 
Breast 
Absolute -5 & 5 0.15 0.83 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.12 0.20 0.0246 Yes 
Liver 
Absolute -5 & 5 4.60 6.62 0.9072 No 
No 
Relative -0.20 & 0.20 0.21 0.27 0.9966 No 
Skin 
Absolute -5 & 5 2.66 3.32 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.32 0.38 >0.9999 No 
Bone 
Surface 
Absolute -5 & 5 4.50 5.59 0.5798 No 
No 
Relative -0.20 & 0.20 0.31 0.36 >0.9999 No 
Adrenals 
Absolute -5 & 5 2.81 5.47 0.0764 No 
No 
Relative -0.20 & 0.20 0.15 0.24 0.3771 No 
Small 
Intestine 
Absolute -5 & 5 7.07 9.60 >0.9999 No 
No 
Relative -0.20 & 0.20 0.29 0.36 >0.9999 No 
Kidney 
Absolute -5 & 5 7.66 9.99 >0.9999 No 
No 
Relative -0.20 & 0.20 0.26 0.31 >0.9999 No 
Pancreas 
Absolute -5 & 5 4.39 6.30 0.7888 No 
No 
Relative -0.20 & 0.20 0.21 0.28 0.9982 No 
Uterus 
Absolute -5 & 5 10.13 13.45 >0.9999 No 
No 
Relative -0.20 & 0.20 0.37 0.46 >0.9999 No 
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Figure 4-1: Absolute difference graph between SSOD and NAOD 
The red lines represent the clinically similar limits set for the statistical test. The 
diamonds represent the average dose estimate with the error bars showing the tabulated 
CI. The estimate models pass this statistical test if the CI values, error bars, are 
completely within the area between the red lines. 
 
Figure 4-2: Relative difference graph between SSOD and NAOD (See Figure 4-1 description)  
-6
-4
-2
0
2
4
6
8
10
12
14
16
D
if
fe
re
n
ce
 (
m
G
y
) 
Absolute Difference (SSOD vs NAOD) 
Colon 
Lung 
Stomach 
Bladder 
Breast 
Liver 
Skin 
Bone 
Surface 
Adrenals 
Small 
Intestine 
Kidney 
Pancreas 
Uterus Gonads 
Bone 
Marrow 
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
D
if
fe
re
n
ce
 
Relative Difference (SSOD vs NAOD) 
Colon 
Lung 
Stomach 
Bladder 
Breast 
Liver Skin 
Bone 
Surface 
Adrenals 
Small 
Intestine 
Kidney 
Pancreas 
Uterus Gonads 
Bone 
Marrow 
 35 
 
Next, the SSOD method versus the SAOD method is summarized in Table 4-3. Figure 
4-3 and Figure 4-4 show the graphical representation of the pair-wise comparison. The absolute 
difference null hypothesis is rejected with all organs except the bladder. So, the bladder absolute 
dose difference between these two estimate methods exceeds the absolute difference criteria but 
only with a p-value of 0.0418. The relative null hypothesis is not rejected with the lung and 
breast dose estimates. The null is rejected in favor of the alternative hypothesis for every other 
organ. Under the definition we listed in Section 3.2.4, the SSOD and the SAOD are clinically 
similar for all organs. In other words, with 88% confidence, the difference between the SSOD 
and SAOD models is either less than 20% or less than 5 mGy for any organ. 
Table 4-3: SSOD versus SAOD pair-wise t-tests 
Organ 
Difference 
Type 
Hypothetical 
Mean 
Confidence 
Intervals 
Max 
p-Value 
Reject 
Null? 
Clinically 
Similar? 
97% CL 
Gonads 
Absolute -5 & 5 1.67 2.92 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.09 0.12 <0.0001 Yes 
Bone 
Marrow 
Absolute -5 & 5 -0.03 0.22 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.00 0.02 <0.0001 Yes 
Colon 
Absolute -5 & 5 0.21 1.28 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.00 0.03 <0.0001 Yes 
Lung 
Absolute -5 & 5 -1.43 -0.63 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.25 -0.15 0.5115 No 
Stomach 
Absolute -5 & 5 -2.239 -0.70 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.10 -0.04 <0.0001 Yes 
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(Table 4-3 Continued) 
Organ 
Difference 
Type 
Hypothetical 
Mean 
Confidence 
Intervals 
Max 
p-Value 
Reject 
Null? 
Clinically 
Similar? 
97% CL 
Bladder 
Absolute -5 & 5 3.03 5.23 0.0418 No 
Yes 
Relative -0.20 & 0.20 0.09 0.15 <0.0001 Yes 
Breast 
Absolute -5 & 5 -0.34 -0.11 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.22 -0.13 0.078 No 
Liver 
Absolute -5 & 5 -3.03 -1.05 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.13 -0.06 <0.0001 Yes 
Skin 
Absolute -5 & 5 0.12 0.30 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.01 0.02 <0.0001 Yes 
Bone 
Surface 
Absolute -5 & 5 -0.13 0.21 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.01 0.01 <0.0001 Yes 
Adrenals 
Absolute -5 & 5 -4.25 -1.42 0.0006 Yes 
Yes 
Relative -0.20 & 0.20 -0.19 -0.09 0.007 Yes 
Small 
Intestine 
Absolute -5 & 5 -0.81 0.70 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.03 0.01 <0.0001 Yes 
Kidney 
Absolute -5 & 5 -1.90 -0.15 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.08 -0.02 <0.0001 Yes 
Pancreas 
Absolute -5 & 5 -2.63 -0.82 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.13 -0.05 <0.0001 Yes 
Uterus 
Absolute -5 & 5 2.04 3.95 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 0.06 0.12 <0.0001 Yes 
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Figure 4-3: Absolute difference graph between SSOD and SAOD 
The red lines represent the clinically similar limits set for the statistical test. The 
diamonds represent the average dose estimate with the error bars showing the tabulated 
CI. The estimate models pass this statistical test if the CI values, error bars, are 
completely within the area between the red lines. 
 
 
Figure 4-4: Relative difference graph between SSOD and SAOD (See Figure 4-3 description) 
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4.2 Effective Dose Summary 
4.2.1 ANOVA Test 
Table 4-4 shows the results of our RM-ANOVA and sphericity assumption tests for 
effective dose. The sphericity null hypothesis is rejected at a=0.05 so the G-G adjusted p-value 
was used for our RM-ANOVA. All the null hypotheses for the RM-ANOVA organ dose 
comparisons are rejected at α = 0.05. Since the hypothesis is rejected, the alternative hypothesis 
is accepted; the three effective dose estimation methods are not all equal.  
Table 4-4: Effective dose RM-ANOVA test result 
  
Sphericity 
Test  
p-Value 
Sphericity 
Rejected? 
F-value 
Non-
Adjusted 
p-Value 
G-G 
Adjusted 
p-Value 
Null 
Rejected? 
(α=0.05) 
Effective 
Dose <0.0001 Yes 24.23 <0.0001 <0.0001 Yes 
 
4.2.2 Post-hoc t-tests 
The estimation method pairing is listed with each type of difference test, absolute and 
relative. The experiment-wise alpha level is set at a=0.12. So, the individual pair-wise alpha 
level is a=0.01 due to the Bonferroni adjustment. There are three method comparisons, two 
difference types, and absolute and relative for a total of six pairings. The lower and upper bounds 
of the 98% CI is listed in Table 4-5.  
The first pair-wise test is the SED estimate method versus the k-factor estimate method. 
The null hypothesis is not rejected for the absolute difference but is rejected for the relative 
difference null hypothesis. So, with a p-value of 0.9991, the absolute difference between the 
SED method and the k-factor method is not between -0.5 and 0.5 mSv. Yet, the two estimation 
methods are within our relative difference criteria of ±0.20 with a p-value of <0.0001. For the 
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SED method versus the AED method, the null hypothesis is rejected in favor of the alternative in 
both tests. So, the two estimation methods are within our absolute difference criteria of ± 0.5 
mSv and relative difference criteria of ±0.20 with p-value of <0.0001 for each. For the final 
method comparison, the AED method versus the k-factor estimation method, the null hypothesis 
is not rejected for the absolute difference but the null is rejected for the relative difference test. 
So, the difference between these methods is greater than 0.5 mSv, with a p-value of 0.9995. The 
two estimation methods are within the relative difference criteria of ±0.20 with a p-value of 
<0.0001. All three pair-wise groups reject at least one of our two null hypotheses, absolute or 
relative. So, all three methods are clinically similar. All the pair-wise effective dose comparisons 
are summarized in Table 4-5, Figure 4-5 and Figure 4-6. 
Table 4-5: Effective dose pair-wise t-tests 
Comparison 
Effective 
Dose 
Difference 
Type 
Hypothetical 
Mean 
Confidence 
Intervals 
p-Value 
Reject 
Null? 
Clinically 
Similar? 
98% CL 
SED vs k-
factor 
Absolute -0.5 & 0.5 0.8 2.4 0.9991 No 
Yes 
Relative -0.20 & 0.20 0.043 0.142 <0.0001 Yes 
SED vs 
AED 
Absolute -0.5 & 0.5 -0.11 0.12 <0.0001 Yes 
Yes 
Relative -0.20 & 0.20 -0.014 0.004 <0.0001 Yes 
AED vs k-
factor 
Absolute -0.5 & 0.5 0.84 2.36 0.9995 No 
Yes 
Relative -0.20 & 0.20 0.05 0.144 <0.0001 Yes 
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Figure 4-5: Effective dose absolute difference graph 
The red lines represent the clinically similar limits set for the statistical test. The 
diamonds represent the average dose estimate with the error bars showing the tabulated 
CI. The estimate models pass this statistical test if the CI values, error bars, are 
completely within the area between the red lines. 
 
Figure 4-6: Effective dose relative difference graph (See Figure 4-5 description) 
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4.3 Discussion 
The SSOD and the NAOD methods were only clinically similar for bone marrow, lung, 
breast and skin. Also, notice that all the differences were positive here. This implies that the 
NAOD method always underestimated dose compared to the SSOD. On the other hand, the 
SSOD and the SAOD were clinically similar for all organs. There were interesting differences 
between the two, though. The SAOD underestimated dose for the gonads, colon, bladder, skin, 
and uterus compared to the SSOD method. The lung and breast SAOD estimate is overestimated 
compared to the SSOD estimate. All three pair-wise effective dose estimate methods were 
clinically similar. The SED and AED estimate were very similar values. The k-factor method 
underestimated the effective dose compared to each of the other two methods but was within 
acceptable limits defined by the clinically similar criteria. 
For organ dose estimation, the ImPACT CT dosimetry software was used for the Non-
size Average Organ Dose estimation method (NAOD), the Size Average Organ Dose estimation 
method (SAOD), and the Size Slice Organ Dose estimation method (SSOD). The NAOD method 
is the easiest, using only the average CT dose report parameters without any patient specific size 
adjustment on the organ doses. The SAOD estimation method was the same as the NAOD with a 
size adjustment on the organ doses based on the patient’s average effective diameter. The SSOD 
was the most complicated method, requiring organ dose estimates for each individual CT slice 
along with size adjustments on each slice organ dose. The SSOD and NAOD methods were not 
clinically similar except for the bone marrow, lung, breast, and skin organs. The SSOD and 
SAOD methods were clinically similar for all organs. 
No patient size adjustments were made for the three effective dose estimation methods. 
The k-factor method is a conventional estimation model that uses the CT scan DLP and a simple 
conversion coefficient from a table to find the effective dose. The k-factor method was the 
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simplest of the three models. The Average Effective Dose (AED) method was calculated with 
ImPACT based on the average CT parameters found in the CT dose report. Finally, the Slice 
Effective Dose (SED) method was estimated by calculating the effective dose contribution from 
each slice. The SED method was obviously the most tedious. All three models were clinically 
similar to each other. The k-factor method slightly underestimated the effective dose compared 
to the other two models but the differences were within the clinically similar criteria. Finally, 
there was no significant difference between the SED and AED estimation methods. 
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 CONCLUSION CHAPTER 5.
This study demonstrated several similarities between the various dose estimation models. 
Impending laws and rule changes have guided physicists to search for simpler, yet equally 
accurate, organ and effective dose estimation methods. The primary goal of this study was to 
compare methods with varying degrees of difficulty to find if the different models are similar 
enough to justify using the more trivial methods in a clinical setting for Urogram protocol patient 
specific TCM-CT dose estimates. Since the SAOD dose method was clinically similar to the 
theoretically more accurate SSOD method, we recommend that physicists use the less complex 
SAOD method for patient specific TCM-CT Urogram organ dose estimates. The NAOD method, 
on the other hand, should not be used unless the specific patient closely matches the 
mathematical phantom parameters. Also, for effective dose estimates, the theoretically more 
accurate SED method provided results indistinguishable from the AED method and results that 
were clinically similar to the k-factor method. So, we recommend that physicists use any of the 
three effective dose estimation methods presented here for TCM-CT Urogram scans. 
There are several caveats in this study. First, only Urogram protocol scans were analyzed. 
Size variability is fairly large for a Urogram protocol, which covers the pelvis, abdomen and 
lower thorax, compared to pure abdomen or thorax scans. So, our conclusion that the SAOD 
estimation method is adequate is conservative for most scans but not for a full body scan, which 
has a much larger size variation. Also, the Urogram protocol only partially exposes the lung and 
breast. We need more studies to find whether the effective diameter conversion factor, EDCF, is 
adequate for partially exposed organs. 
Organ coverage depends on the patient height but we do not take that into account. This 
is not necessarily a problem since we can adjust the scan range to account for this in the 
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ImPACT program. Yet, we do not have a clear indication that adjusting the scan range to account 
for patient height provides an accurate adjustment for height. Further studies can take patient 
height into account with simple height dependent conversion factors. 
Finally, we make the assumption that the slice by slice methods are more accurate but 
they are not necessarily the best standard to compare with our average estimation models. We 
plan to investigate our results further using Monte Carlo simulations or actual dose 
measurements in various phantoms as a true accurate comparison metric. We plan to perform 
this study across different protocols and patient height and thickness parameters.  
 45 
 
REFERENCES 
AAPM. (2011, December). AAPM Government Affairs. Retrieved 1 14, 2014, from AAPM: 
https://www.aapm.org/government_affairs/documents/SB-1237Section3_v7.pdf. 
AAPM Task Group 23. (2008). AAPM Report No. 96, The Measurement, Reporting, and 
Management of Radiation Dose in CT. College Park: American Association of Physicists 
in Medicine. 
AAPM Task Group 204. (2011). AAPM 204: Size-Specifice Dose Estimates (SSDE) in Pediatric 
and Adult Body CT Examinations. College Park: American Association of Physicists in 
Medicine. 
ACR-AAPM. (2013). ACR–AAPM Resolution No. 47: Practice Guidline for Diagnostic 
Reference Levels and Achievable Doses in Medical X-Ray Imaging. ACR-AAPM. 
Boone, J. (2007). The trouble with CTDI100. Medical Physics, 1364-1371. 
Bushberg, J. T., Seibert, J. A., Leidholdt, Jr., E. M., & Boone, J. M. (2012). The Essential 
Physics of Medical Imaging. Philadelphia, PA: Lippincott Williams & Wilkins. 
Freund, R. J., Wilson, W. J., & Mohr, D. L. (2010). Statistical Methods. Amsterdam: Elsevier. 
GE Healthcare. (2012). A Guide to CT Radiation Dose Management. Wauwatosa: General 
Electric Company. 
ImPACT Scan Working Group. (2013, May). A Brief History of CT. Retrieved May 2014, 13, 
from ImPACT Scan: http://www.impactscan.org/CThistory.htm. 
Khatonabadi, M., Hyun, J. K., Lu, P., McMillan, K. L., Cagnon, C. H., DeMarco, J. J., & 
McNitt-Gray, M. F. (2013). The feasibility of a regional CTDIvol to estimate organ dose 
from tube current modulated CT exams. Medical Physics, 1-11. 
Lee, C., Kim, K. P., Long, D., Fisher, R., Tien, C., Simon, S. L., . . . Bolch, W. E. (2012). Organ 
doses for the reference pediatric and adolescent patients undergoing computed 
tomography esteimated by Monte Carlo simulation. Medical Physics, 2129-2146. 
McCollough, C. (2008). CT dose: How to measure, how to reduce. Health Physics, 508-517. 
McNitt-Gray, M. F. (2011). Assessing Radiation Dose: How to do it right. AAPM Summit on CT 
Dose. Denver: AAPM. 
NCRP. (2009). NCRP 160: Ionizing Radiation Exposure of the Population of the United States. 
Bethesda: National Council on Radiation Protection. 
The Joint Commission. (2013, May 5). Prepublication - Diagnostic Imaging Services 
Requirements: Update; Delayed Implementation. Retrieved from The Joint Commission: 
http://www.jointcommission.org/standards_information/prepublication_standards.aspx. 
 46 
 
Turner, A. C., Zhang, D., Khatonabadi, M., Zankl, M., McNitt-Gray, M. F., DeMarco, J. J., . . . 
McNitt-Gray, M. F. (2011). The feasibility of patient size-corrected, scanner-independent 
organ dose estimates fo rabdominal CT exams. Medical Physics, 820-821. 
 
  
 47 
 
APPENDIX A. STATISTICS 
The RM-ANOVA test depends on two key assumptions. First, it is sensitive to large 
violations of normality. So we tested each estimate method’s results against a normal distribution 
with the same mean and standard error with a    Goodness of Fit test. We used Microsoft Excel 
to create 14 bins for the data. The data was binned such that the two extreme data points were in 
the 1 or 2 and the 13 or 14 bin. Our normal distribution mirrored the same bin structure with 
matching mean bins. We present the    test statistic, the degrees of freedom and the p-value for 
each organ dose and effective dose in Table A-1 and Table A-2.  
Table A-1: Organ dose normality tests 
  
  
Organ 
NAOD SAOD SSOD 
   df p-value    df p-value    df p-value 
1 Gonads 5.94 9.00 0.75 8.62 8.00 0.38 8.09 8.00 0.42 
2 Bone Marrow 12.17 9.00 0.20 14.95 9.00 0.09 11.36 10.00 0.33 
3 Colon 11.33 9.00 0.25 16.74 10.00 0.08 17.19 9.00 0.05 
4 Log(Lung) 10.32 9.00 0.33 15.08 8.00 0.06 8.20 8.00 0.41 
5 Stomach 10.87 10.00 0.37 18.52 10.00 0.05 4.58 11.00 0.95 
6 Bladder 10.22 9.00 0.33 14.25 10.00 0.16 14.13 9.00 0.12 
7 Log(Breast) 15.42 8.00 0.05 63.47 8.00 0.00 32.33 10.00 0.00 
8 Liver 7.65 9.00 0.57 15.18 8.00 0.06 11.33 9.00 0.25 
9 Skin 10.12 9.00 0.34 11.77 8.00 0.16 9.54 7.00 0.22 
10 Bone Surface 14.72 10.00 0.14 11.22 9.00 0.26 7.75 9.00 0.56 
11 Adrenals 10.83 11.00 0.46 12.50 8.00 0.13 11.98 9.00 0.21 
12 Small Intestine 11.03 10.00 0.35 17.20 9.00 0.05 10.83 9.00 0.29 
13 Kidney 14.68 9.00 0.10 13.18 9.00 0.15 15.78 9.00 0.07 
14 Pancreas 14.83 9.00 0.10 14.08 7.00 0.05 12.17 8.00 0.14 
15 Uterus 11.44 9.00 0.25 9.15 8.00 0.33 14.71 7.00 0.04 
 
Table A-2: Effective dose normality tests 
 
k-factor AED SED 
   df p-value    df p-value    df p-value 
Effective dose 11.13 11.13 0.19 14.16 9.00 0.12 12.87 9.00 0.17 
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Most p-values were greater than 0.05 so we do not reject the null hypothesis of normality 
for those dose estimates. The exceptions were the lung, breast, and the SSOD uterus estimates. 
The lung and breast dose estimates violated the normality assumption so we performed a natural 
log transform action on the data to see if the fit was better. This transformation normalized the 
lung dose but not for the breast dose. We reject the hypotheses of normality for the SAOD and 
SSOD breast dose. The SSOD uterus doses did not fit a normal distribution, p-value = 0.04, but 
we continued with the statistical tests anyway. 
The second assumption for the RM-ANOVA is the sphericity assumption. Sphericity 
plays a similar role in RM-ANOVA as assumption of independence and constant variance plays 
in ordinary ANOVA (Freund, Wilson, & Mohr, 2010). In particular, sphericity measures the 
similarity of the variance of the differences between the pair-wise combinations in the RM-
ANOVA models. We use the Mauchely’s Test of sphericity with SAS statistics software. 
Various methods are available to account for violations of sphericity. We use the Greenhouse-
Geisser (G-G) adjustment on the degrees of freedom which is similar to the Satterthwaite 
adjustment for t-test of unequal variances (Freund, Wilson, & Mohr, 2010). The adjusted G-G 
degrees of freedom are then used to calculate appropriate p-values. 
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APPENDIX B. SCAN DATA AND DOSE ESTIMATES 
We present the results of each scan estimate in the following tables along with specific 
scan parameters. We do not provide specific tables of slice by slice calculations since the 
calculation tables are much too large to provide in the thesis. The results of those calculations are 
provided, however. 
Effective dose data 
 
Sex Start End 
Scan 
Length 
cm 
Scanner Pitch 
Avg 
Current 
CTDI 
vol 
DLP 
k Factor 
(Abd-
Pelv) 
SED AED 
DLP k 
factor 
Method 
1 M 19.5 47 27.5 GE 1.375 459.34 15.90 699.60 0.015 8.46 8.20 10.49 
2 M 21.5 51 29.5 Toshiba 0.828 430.25 31.10 1368.40 0.015 19.26 19.00 20.53 
3 F 1.5 36.5 35 GE 1.375 124.68 4.30 189.20 0.015 2.28 2.40 2.84 
4 F 1.5 36.5 35 GE 1.375 124.95 4.30 189.20 0.015 2.29 2.40 2.84 
5 F 0.5 38 37.5 Toshiba 0.828 203.64 14.70 646.80 0.015 8.75 8.90 9.70 
6 F 3.5 41 37.5 Toshiba 0.828 203.64 14.70 646.80 0.015 9.43 9.50 9.70 
7 M 0.5 39.5 39 GE 1.375 344.87 11.90 523.60 0.015 7.57 7.50 7.85 
8 F 2.5 42.5 40 Toshiba 0.828 229.31 16.60 730.40 0.015 11.28 11.00 10.96 
9 F 3 43 40 Toshiba 0.828 242.53 17.50 770.00 0.015 12.00 12.00 11.55 
10 M -1 39.5 40.5 GE 1.375 424.69 14.70 646.80 0.015 9.84 9.40 9.70 
11 M -1 39.5 40.5 GE 1.375 424.99 14.70 646.80 0.015 9.84 9.40 9.70 
12 F -1 39.5 40.5 GE 1.375 494.60 17.10 752.40 0.015 10.77 11.00 11.29 
13 F -1 39.5 40.5 GE 1.375 497.70 17.20 756.80 0.015 10.82 11.00 11.35 
14 F 2.5 43.5 41 GE 1.375 227.20 7.90 347.60 0.015 5.30 5.40 5.21 
15 F 4 45.5 41.5 GE 1.375 193.39 6.70 294.80 0.015 4.58 4.70 4.42 
16 F -0.5 41.5 42 GE 1.375 193.24 6.70 294.80 0.015 4.30 4.50 4.42 
17 F 3.5 45.5 42 GE 1.375 276.61 9.60 422.40 0.015 6.71 6.90 6.34 
18 F 3.5 45.5 42 GE 1.375 276.74 9.60 422.40 0.015 6.72 6.90 6.34 
19 M 0.2 42.2 42 GE 1.375 295.78 10.20 448.80 0.015 6.84 7.00 6.73 
20 M 0.2 42.7 42.5 GE 1.375 295.39 10.20 448.80 0.015 6.89 7.10 6.73 
21 F 1.3 43.8 42.5 Toshiba 1.484 345.29 13.90 611.60 0.015 9.96 9.90 9.17 
22 M -5.5 38 43.5 Toshiba 0.828 160.77 11.60 510.40 0.015 7.71 7.90 7.66 
23 M 3 46.5 43.5 Toshiba 0.828 160.77 11.60 510.40 0.015 8.73 8.70 7.66 
24 F 1 45 44 Toshiba 0.828 201.88 14.60 642.40 0.015 10.53 11.00 9.64 
25 F 1 45 44 Toshiba 1.485 273.52 11.00 484.00 0.015 8.01 8.20 7.26 
26 M 0.5 44.5 44 Toshiba 0.828 286.49 20.70 910.80 0.015 15.25 15.00 13.66 
27 F 1 45.5 44.5 Toshiba 0.828 270.89 19.60 862.40 0.015 14.47 15.00 12.94 
28 M 6.5 51 44.5 Toshiba 0.828 296.26 21.40 941.60 0.015 18.07 18.00 14.12 
29 M -2 42.5 44.5 Toshiba 0.69 297.81 25.80 1135.20 0.015 18.82 19.00 17.03 
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30 F 1 45.5 44.5 Toshiba 1.485 326.53 13.20 580.80 0.015 9.94 9.90 8.71 
31 F 2.5 47 44.5 Toshiba 0.828 336.28 24.30 1069.20 0.015 18.41 19.00 16.04 
32 M 0 45 45 Toshiba 0.828 297.81 21.50 946.00 0.015 16.00 16.00 14.19 
33 M 0 45 45 Toshiba 0.828 297.81 21.50 946.00 0.015 16.00 16.00 14.19 
34 F 3.5 48.5 45 Toshiba 0.828 337.42 24.90 1095.60 0.015 19.02 19.00 16.43 
35 F 1.5 48 46.5 Toshiba 0.828 291.40 21.10 928.40 0.015 16.50 17.00 13.93 
36 F -0.5 47 47.5 Toshiba 0.828 333.65 24.10 1060.40 0.015 19.43 19.00 15.91 
37 F 2 49.5 47.5 Toshiba 1.484 374.06 15.10 664.40 0.015 12.67 12.00 9.97 
38 M -2 47 49 Toshiba 0.828 306.99 22.20 976.80 0.015 18.44 18.00 14.65 
39 M 1 50 49 Toshiba 0.828 309.13 22.30 981.20 0.015 19.10 19.00 14.72 
40 M -5.5 43.5 49 Toshiba 0.828 317.92 23.00 1012.00 0.015 18.11 18.00 15.18 
41 M -5.5 43.5 49 Toshiba 0.828 317.92 23.00 1012.00 0.015 18.11 18.00 15.18 
42 M -2 47 49 GE 1.375 453.91 15.70 690.80 0.015 12.82 13.00 10.36 
43 M -2 47 49 GE 1.375 455.87 15.70 690.80 0.015 12.87 13.00 10.36 
44 M -6 44 50 Toshiba 0.828 268.34 19.40 853.60 0.015 15.16 16.00 12.80 
45 M -0.5 51 51.5 Toshiba 0.828 410.55 29.70 1306.80 0.015 27.47 27.00 19.60 
46 M -0.5 51 51.5 Toshiba 0.828 410.55 29.70 1306.80 0.015 27.47 27.00 19.60 
47 M -1 52.5 53.5 Toshiba 0.828 349.48 25.20 1108.80 0.015 24.91 24.00 16.63 
48 M -1 52.5 53.5 Toshiba 1.485 406.91 16.40 721.60 0.015 16.10 16.00 10.82 
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Gonad organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 1.61 1.60 2.02 2.05 
2 M 21.5 51 29.5 322.24 430.25 1.14 2.30 2.10 2.61 2.39 
3 F 1.5 36.5 35 221.01 124.68 1.65 3.60 3.10 5.86 5.12 
4 F 1.5 36.5 35 221.01 124.95 1.65 3.61 3.10 5.88 5.12 
5 F 0.5 38 37.5 251.35 203.64 1.48 12.82 11.00 18.92 16.28 
6 F 3.5 41 37.5 251.35 203.64 1.48 11.53 10.00 16.97 14.80 
7 M 0.5 39.5 39 257.16 344.87 1.48 9.00 8.90 13.19 13.17 
8 F 2.5 42.5 40 247.69 229.31 1.53 13.86 12.00 21.02 18.36 
9 F 3 43 40 247.69 242.53 1.53 14.37 12.00 21.82 18.36 
10 M -1 39.5 40.5 264.81 424.69 1.43 12.26 13.00 17.85 18.59 
11 M -1 39.5 40.5 264.81 424.99 1.43 12.27 13.00 17.87 18.59 
12 F -1 39.5 40.5 278.83 494.60 1.37 17.59 15.00 23.29 20.55 
13 F -1 39.5 40.5 278.83 497.70 1.37 17.64 15.00 23.36 20.55 
14 F 2.5 43.5 41 250.71 227.20 1.48 6.20 5.50 9.04 8.14 
15 F 4 45.5 41.5 229.62 193.39 1.65 5.61 4.50 8.58 7.43 
16 F -0.5 41.5 42 229.75 193.24 1.65 6.58 5.40 10.34 8.91 
17 F 3.5 45.5 42 259.45 276.61 1.48 7.49 6.50 10.56 9.62 
18 F 3.5 45.5 42 254.94 276.74 1.48 7.50 6.50 11.09 9.62 
19 M 0.2 42.2 42 254.94 295.78 1.48 8.48 7.80 12.56 11.54 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 8.17 7.80 11.95 11.54 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 11.37 10.00 15.75 14.30 
22 M -5.5 38 43.5 235.98 160.77 1.59 19.99 17.00 32.13 27.03 
23 M 3 46.5 43.5 235.98 160.77 1.59 9.55 8.10 15.12 12.88 
24 F 1 45 44 250.94 201.88 1.48 13.54 11.00 19.96 16.28 
25 F 1 45 44 250.11 273.52 1.48 9.99 8.30 14.79 12.28 
26 M 0.5 44.5 44 272.22 286.49 1.37 17.16 16.00 24.49 21.92 
27 F 1 45.5 44.5 268.07 270.89 1.43 17.79 15.00 24.78 21.45 
28 M 6.5 51 44.5 276.03 296.26 1.37 14.30 14.00 20.32 19.18 
29 M -2 42.5 44.5 282.05 297.81 1.32 32.14 28.00 44.14 36.96 
30 F 1 45.5 44.5 264.85 326.53 1.43 10.64 9.80 15.03 14.01 
31 F 2.5 47 44.5 306.76 336.28 1.23 19.03 17.00 22.97 20.91 
32 M 0 45 45 276.59 297.81 1.37 19.70 17.00 26.98 23.29 
33 M 0 45 45 276.59 297.81 1.37 19.70 17.00 26.98 23.29 
34 F 3.5 48.5 45 306.89 337.42 1.23 18.83 17.00 22.82 20.91 
35 F 1.5 48 46.5 267.80 291.40 1.43 18.12 15.00 25.18 21.45 
36 F -0.5 47 47.5 295.37 333.65 1.28 21.36 20.00 27.49 25.60 
37 F 2 49.5 47.5 296.51 374.06 1.28 11.33 11.00 14.48 14.08 
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38 M -2 47 49 275.87 306.99 1.37 27.45 24.00 37.62 32.88 
39 M 1 50 49 271.62 309.13 1.37 18.33 17.00 25.83 23.29 
40 M -5.5 43.5 49 290.19 317.92 1.28 37.90 35.00 50.60 44.80 
41 M -5.5 43.5 49 291.48 317.92 1.28 37.90 35.00 50.35 44.80 
42 M -2 47 49 295.09 453.91 1.28 17.39 16.00 22.34 20.48 
43 M -2 47 49 295.09 455.87 1.28 17.55 17.00 22.54 21.76 
44 M -6 44 50 262.67 268.34 1.43 34.96 29.00 50.33 41.47 
45 M -0.5 51 51.5 312.61 410.55 1.19 24.79 24.00 30.59 28.56 
46 M -0.5 51 51.5 312.61 410.55 1.19 24.79 24.00 30.59 28.56 
47 M -1 52.5 53.5 296.56 349.48 1.28 23.60 22.00 31.38 28.16 
48 M -1 52.5 53.5 296.56 406.91 1.28 15.26 15.00 20.29 19.20 
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Bone Marrow organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 5.47 5.30 6.93 6.78 
2 M 21.5 51 29.5 322.24 430.25 1.14 11.40 11.00 13.21 12.54 
3 F 1.5 36.5 35 221.01 124.68 1.65 2.06 2.00 3.44 3.30 
4 F 1.5 36.5 35 221.01 124.95 1.65 2.07 2.00 3.45 3.30 
5 F 0.5 38 37.5 251.35 203.64 1.48 7.50 7.30 11.21 10.80 
6 F 3.5 41 37.5 251.35 203.64 1.48 7.85 7.50 11.68 11.10 
7 M 0.5 39.5 39 257.16 344.87 1.48 5.96 6.10 8.73 9.03 
8 F 2.5 42.5 40 247.69 229.31 1.53 9.33 8.90 14.16 13.62 
9 F 3 43 40 247.69 242.53 1.53 9.75 9.50 14.80 14.54 
10 M -1 39.5 40.5 264.81 424.69 1.43 7.30 7.60 10.37 10.87 
11 M -1 39.5 40.5 264.81 424.99 1.43 7.30 7.60 10.38 10.87 
12 F -1 39.5 40.5 278.83 494.60 1.37 8.75 8.90 11.79 12.19 
13 F -1 39.5 40.5 278.83 497.70 1.37 8.79 9.00 11.83 12.33 
14 F 2.5 43.5 41 250.71 227.20 1.48 4.34 4.20 6.48 6.22 
15 F 4 45.5 41.5 229.62 193.39 1.65 3.85 3.70 6.13 6.11 
16 F -0.5 41.5 42 229.75 193.24 1.65 3.58 3.60 5.80 5.94 
17 F 3.5 45.5 42 259.45 276.61 1.48 5.47 5.40 7.91 7.99 
18 F 3.5 45.5 42 254.94 276.74 1.48 5.48 5.40 8.10 7.99 
19 M 0.2 42.2 42 254.94 295.78 1.48 5.44 5.60 8.07 8.29 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 5.48 5.60 8.16 8.29 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 8.10 7.90 11.38 11.30 
22 M -5.5 38 43.5 235.98 160.77 1.59 5.77 6.10 9.28 9.70 
23 M 3 46.5 43.5 235.98 160.77 1.59 7.05 6.80 11.19 10.81 
24 F 1 45 44 250.94 201.88 1.48 8.98 8.60 13.39 12.73 
25 F 1 45 44 250.11 273.52 1.48 6.83 6.50 10.20 9.62 
26 M 0.5 44.5 44 272.22 286.49 1.37 12.22 12.00 17.04 16.44 
27 F 1 45.5 44.5 268.07 270.89 1.43 12.07 12.00 16.99 17.16 
28 M 6.5 51 44.5 276.03 296.26 1.37 13.76 13.00 18.92 17.81 
29 M -2 42.5 44.5 282.05 297.81 1.32 14.82 15.00 20.02 19.80 
30 F 1 45.5 44.5 264.85 326.53 1.43 7.97 7.80 11.42 11.15 
31 F 2.5 47 44.5 306.76 336.28 1.23 14.83 15.00 18.04 18.45 
32 M 0 45 45 276.59 297.81 1.37 13.16 13.00 17.92 17.81 
33 M 0 45 45 276.59 297.81 1.37 13.16 13.00 17.92 17.81 
34 F 3.5 48.5 45 306.89 337.42 1.23 15.17 15.00 18.51 18.45 
35 F 1.5 48 46.5 267.80 291.40 1.43 13.57 13.00 19.04 18.59 
36 F -0.5 47 47.5 295.37 333.65 1.28 15.37 15.00 19.42 19.20 
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37 F 2 49.5 47.5 296.51 374.06 1.28 9.93 9.60 12.54 12.29 
38 M -2 47 49 275.87 306.99 1.37 14.19 14.00 19.33 19.18 
39 M 1 50 49 271.62 309.13 1.37 15.13 15.00 21.16 20.55 
40 M -5.5 43.5 49 290.19 317.92 1.28 13.75 14.00 17.83 17.92 
41 M -5.5 43.5 49 291.48 317.92 1.28 13.75 14.00 17.72 17.92 
42 M -2 47 49 295.09 453.91 1.28 9.62 9.70 12.23 12.42 
43 M -2 47 49 295.09 455.87 1.28 9.70 9.80 12.33 12.54 
44 M -6 44 50 262.67 268.34 1.43 11.48 12.00 16.59 17.16 
45 M -0.5 51 51.5 312.61 410.55 1.19 20.54 20.00 24.37 23.80 
46 M -0.5 51 51.5 312.61 410.55 1.19 20.54 20.00 24.37 23.80 
47 M -1 52.5 53.5 296.56 349.48 1.28 18.04 18.00 22.90 23.04 
48 M -1 52.5 53.5 296.56 406.91 1.28 11.69 12.00 14.84 15.36 
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Colon organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 10.61 11.00 13.37 14.08 
2 M 21.5 51 29.5 322.24 430.25 1.14 19.11 19.00 21.49 21.66 
3 F 1.5 36.5 35 221.01 124.68 1.65 5.38 5.50 9.11 9.08 
4 F 1.5 36.5 35 221.01 124.95 1.65 5.39 5.50 9.13 9.08 
5 F 0.5 38 37.5 251.35 203.64 1.48 19.74 19.00 29.71 28.12 
6 F 3.5 41 37.5 251.35 203.64 1.48 19.33 19.00 28.99 28.12 
7 M 0.5 39.5 39 257.16 344.87 1.48 14.29 16.00 21.35 23.68 
8 F 2.5 42.5 40 247.69 229.31 1.53 21.76 21.00 33.56 32.13 
9 F 3 43 40 247.69 242.53 1.53 22.18 22.00 34.19 33.66 
10 M -1 39.5 40.5 264.81 424.69 1.43 17.94 19.00 25.73 27.17 
11 M -1 39.5 40.5 264.81 424.99 1.43 17.95 19.00 25.74 27.17 
12 F -1 39.5 40.5 278.83 494.60 1.37 21.75 23.00 29.61 31.51 
13 F -1 39.5 40.5 278.83 497.70 1.37 21.85 23.00 29.75 31.51 
14 F 2.5 43.5 41 250.71 227.20 1.48 10.18 10.00 15.49 14.80 
15 F 4 45.5 41.5 229.62 193.39 1.65 8.83 8.20 14.32 13.53 
16 F -0.5 41.5 42 229.75 193.24 1.65 8.66 8.80 14.21 14.52 
17 F 3.5 45.5 42 259.45 276.61 1.48 12.17 12.00 17.63 17.76 
18 F 3.5 45.5 42 254.94 276.74 1.48 12.18 12.00 18.42 17.76 
19 M 0.2 42.2 42 254.94 295.78 1.48 12.60 13.00 19.06 19.24 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 12.57 13.00 19.10 19.24 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 19.26 18.00 27.07 25.74 
22 M -5.5 38 43.5 235.98 160.77 1.59 15.53 16.00 25.07 25.44 
23 M 3 46.5 43.5 235.98 160.77 1.59 15.29 15.00 24.80 23.85 
24 F 1 45 44 250.94 201.88 1.48 19.98 19.00 30.09 28.12 
25 F 1 45 44 250.11 273.52 1.48 15.34 15.00 23.19 22.20 
26 M 0.5 44.5 44 272.22 286.49 1.37 29.81 28.00 41.71 38.36 
27 F 1 45.5 44.5 268.07 270.89 1.43 27.90 26.00 39.30 37.18 
28 M 6.5 51 44.5 276.03 296.26 1.37 26.33 25.00 36.71 34.25 
29 M -2 42.5 44.5 282.05 297.81 1.32 37.75 35.00 51.20 46.20 
30 F 1 45.5 44.5 264.85 326.53 1.43 18.42 17.00 26.60 24.31 
31 F 2.5 47 44.5 306.76 336.28 1.23 33.42 31.00 39.71 38.13 
32 M 0 45 45 276.59 297.81 1.37 31.52 29.00 42.80 39.73 
33 M 0 45 45 276.59 297.81 1.37 31.52 29.00 42.80 39.73 
34 F 3.5 48.5 45 306.89 337.42 1.23 33.03 31.00 39.17 38.13 
35 F 1.5 48 46.5 267.80 291.40 1.43 31.65 28.00 44.24 40.04 
36 F -0.5 47 47.5 295.37 333.65 1.28 33.19 33.00 41.77 42.24 
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37 F 2 49.5 47.5 296.51 374.06 1.28 20.43 20.00 25.71 25.60 
38 M -2 47 49 275.87 306.99 1.37 30.16 30.00 41.71 41.10 
39 M 1 50 49 271.62 309.13 1.37 30.53 30.00 44.02 41.10 
40 M -5.5 43.5 49 290.19 317.92 1.28 33.82 32.00 43.97 40.96 
41 M -5.5 43.5 49 291.48 317.92 1.28 33.82 32.00 43.72 40.96 
42 M -2 47 49 295.09 453.91 1.28 20.05 21.00 25.45 26.88 
43 M -2 47 49 295.09 455.87 1.28 20.22 21.00 25.67 26.88 
44 M -6 44 50 262.67 268.34 1.43 27.01 27.00 39.34 38.61 
45 M -0.5 51 51.5 312.61 410.55 1.19 39.88 40.00 46.94 47.60 
46 M -0.5 51 51.5 312.61 410.55 1.19 39.88 40.00 46.94 47.60 
47 M -1 52.5 53.5 296.56 349.48 1.28 33.96 34.00 43.74 43.52 
48 M -1 52.5 53.5 296.56 406.91 1.28 22.27 22.00 28.66 28.16 
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Lung organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 6.82 6.90 8.73 8.83 
2 M 21.5 51 29.5 322.24 430.25 1.14 23.87 24.00 27.73 27.36 
3 F 1.5 36.5 35 221.01 124.68 1.65 0.11 0.15 0.20 0.25 
4 F 1.5 36.5 35 221.01 124.95 1.65 0.11 0.15 0.20 0.25 
5 F 0.5 38 37.5 251.35 203.64 1.48 0.56 0.74 0.84 1.10 
6 F 3.5 41 37.5 251.35 203.64 1.48 1.06 1.40 1.59 2.07 
7 M 0.5 39.5 39 257.16 344.87 1.48 0.87 0.80 1.19 1.18 
8 F 2.5 42.5 40 247.69 229.31 1.53 1.64 2.20 2.44 3.37 
9 F 3 43 40 247.69 242.53 1.53 1.93 2.60 2.87 3.98 
10 M -1 39.5 40.5 264.81 424.69 1.43 1.20 0.99 1.63 1.42 
11 M -1 39.5 40.5 264.81 424.99 1.43 1.20 0.99 1.63 1.42 
12 F -1 39.5 40.5 278.83 494.60 1.37 0.99 1.20 1.34 1.64 
13 F -1 39.5 40.5 278.83 497.70 1.37 0.99 1.20 1.34 1.64 
14 F 2.5 43.5 41 250.71 227.20 1.48 1.06 1.30 1.55 1.92 
15 F 4 45.5 41.5 229.62 193.39 1.65 1.47 2.10 2.38 3.47 
16 F -0.5 41.5 42 229.75 193.24 1.65 0.50 0.70 0.81 1.16 
17 F 3.5 45.5 42 259.45 276.61 1.48 2.53 3.00 3.70 4.44 
18 F 3.5 45.5 42 254.94 276.74 1.48 2.53 3.00 3.49 4.44 
19 M 0.2 42.2 42 254.94 295.78 1.48 1.09 1.20 1.53 1.78 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 1.22 1.40 1.79 2.07 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 2.23 2.60 3.15 3.72 
22 M -5.5 38 43.5 235.98 160.77 1.59 0.45 0.58 0.68 0.92 
23 M 3 46.5 43.5 235.98 160.77 1.59 3.47 4.70 5.17 7.47 
24 F 1 45 44 250.94 201.88 1.48 3.19 4.10 4.71 6.07 
25 F 1 45 44 250.11 273.52 1.48 2.52 3.10 3.72 4.59 
26 M 0.5 44.5 44 272.22 286.49 1.37 3.30 4.90 4.39 6.71 
27 F 1 45.5 44.5 268.07 270.89 1.43 3.80 6.30 5.42 9.01 
28 M 6.5 51 44.5 276.03 296.26 1.37 16.75 16.00 22.14 21.92 
29 M -2 42.5 44.5 282.05 297.81 1.32 2.35 3.40 3.00 4.49 
30 F 1 45.5 44.5 264.85 326.53 1.43 3.20 4.20 4.56 6.01 
31 F 2.5 47 44.5 306.76 336.28 1.23 8.73 11.00 11.05 13.53 
32 M 0 45 45 276.59 297.81 1.37 4.09 6.00 5.52 8.22 
33 M 0 45 45 276.59 297.81 1.37 4.09 6.00 5.52 8.22 
34 F 3.5 48.5 45 306.89 337.42 1.23 11.16 14.00 14.16 17.22 
35 F 1.5 48 46.5 267.80 291.40 1.43 7.30 11.00 10.36 15.73 
36 F -0.5 47 47.5 295.37 333.65 1.28 10.65 11.00 13.17 14.08 
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37 F 2 49.5 47.5 296.51 374.06 1.28 9.63 9.80 11.97 12.54 
38 M -2 47 49 275.87 306.99 1.37 8.39 9.80 11.13 13.43 
39 M 1 50 49 271.62 309.13 1.37 13.34 15.00 17.30 20.55 
40 M -5.5 43.5 49 290.19 317.92 1.28 2.62 3.90 3.29 4.99 
41 M -5.5 43.5 49 291.48 317.92 1.28 2.62 3.90 3.26 4.99 
42 M -2 47 49 295.09 453.91 1.28 6.84 6.80 8.75 8.70 
43 M -2 47 49 295.09 455.87 1.28 6.82 6.90 8.73 8.83 
44 M -6 44 50 262.67 268.34 1.43 2.46 3.90 3.44 5.58 
45 M -0.5 51 51.5 312.61 410.55 1.19 23.91 23.00 27.78 27.37 
46 M -0.5 51 51.5 312.61 410.55 1.19 23.91 23.00 27.78 27.37 
47 M -1 52.5 53.5 296.56 349.48 1.28 23.26 22.00 27.90 28.16 
48 M -1 52.5 53.5 296.56 406.91 1.28 14.61 14.00 17.53 17.92 
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Stomach organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 24.07 23.00 30.79 29.44 
2 M 21.5 51 29.5 322.24 430.25 1.14 47.41 46.00 55.35 52.44 
3 F 1.5 36.5 35 221.01 124.68 1.65 2.91 4.00 5.06 6.60 
4 F 1.5 36.5 35 221.01 124.95 1.65 2.91 4.00 5.06 6.60 
5 F 0.5 38 37.5 251.35 203.64 1.48 13.58 16.00 20.44 23.68 
6 F 3.5 41 37.5 251.35 203.64 1.48 17.07 19.00 25.81 28.12 
7 M 0.5 39.5 39 257.16 344.87 1.48 14.98 14.00 21.13 20.72 
8 F 2.5 42.5 40 247.69 229.31 1.53 20.79 23.00 31.03 35.19 
9 F 3 43 40 247.69 242.53 1.53 22.58 25.00 33.72 38.25 
10 M -1 39.5 40.5 264.81 424.69 1.43 20.97 17.00 28.75 24.31 
11 M -1 39.5 40.5 264.81 424.99 1.43 20.97 17.00 28.75 24.31 
12 F -1 39.5 40.5 278.83 494.60 1.37 17.67 20.00 23.72 27.40 
13 F -1 39.5 40.5 278.83 497.70 1.37 17.66 20.00 23.71 27.40 
14 F 2.5 43.5 41 250.71 227.20 1.48 9.53 11.00 14.56 16.28 
15 F 4 45.5 41.5 229.62 193.39 1.65 7.46 9.60 12.53 15.84 
16 F -0.5 41.5 42 229.75 193.24 1.65 6.73 8.80 11.10 14.52 
17 F 3.5 45.5 42 259.45 276.61 1.48 11.94 14.00 17.66 20.72 
18 F 3.5 45.5 42 254.94 276.74 1.48 11.94 14.00 17.87 20.72 
19 M 0.2 42.2 42 254.94 295.78 1.48 12.72 14.00 18.57 20.72 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 12.90 14.00 19.56 20.72 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 18.68 20.00 26.99 28.60 
22 M -5.5 38 43.5 235.98 160.77 1.59 10.70 13.00 16.23 20.67 
23 M 3 46.5 43.5 235.98 160.77 1.59 15.95 17.00 25.28 27.03 
24 F 1 45 44 250.94 201.88 1.48 17.21 21.00 26.26 31.08 
25 F 1 45 44 250.11 273.52 1.48 13.44 16.00 20.54 23.68 
26 M 0.5 44.5 44 272.22 286.49 1.37 29.23 30.00 39.56 41.10 
27 F 1 45.5 44.5 268.07 270.89 1.43 25.30 29.00 35.99 41.47 
28 M 6.5 51 44.5 276.03 296.26 1.37 32.82 32.00 44.18 43.84 
29 M -2 42.5 44.5 282.05 297.81 1.32 32.32 36.00 42.27 47.52 
30 F 1 45.5 44.5 264.85 326.53 1.43 19.16 19.00 27.69 27.17 
31 F 2.5 47 44.5 306.76 336.28 1.23 32.91 36.00 41.72 44.28 
32 M 0 45 45 276.59 297.81 1.37 28.79 31.00 39.12 42.47 
33 M 0 45 45 276.59 297.81 1.37 28.79 31.00 39.12 42.47 
34 F 3.5 48.5 45 306.89 337.42 1.23 33.74 37.00 42.45 45.51 
35 F 1.5 48 46.5 267.80 291.40 1.43 28.73 31.00 41.35 44.33 
36 F -0.5 47 47.5 295.37 333.65 1.28 36.39 36.00 45.97 46.08 
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37 F 2 49.5 47.5 296.51 374.06 1.28 23.10 23.00 29.12 29.44 
38 M -2 47 49 275.87 306.99 1.37 33.70 33.00 45.89 45.21 
39 M 1 50 49 271.62 309.13 1.37 33.84 34.00 46.70 46.58 
40 M -5.5 43.5 49 290.19 317.92 1.28 30.46 33.00 38.90 42.24 
41 M -5.5 43.5 49 291.48 317.92 1.28 30.46 33.00 38.55 42.24 
42 M -2 47 49 295.09 453.91 1.28 24.39 23.00 31.18 29.44 
43 M -2 47 49 295.09 455.87 1.28 24.41 23.00 31.21 29.44 
44 M -6 44 50 262.67 268.34 1.43 23.62 28.00 33.76 40.04 
45 M -0.5 51 51.5 312.61 410.55 1.19 48.38 45.00 56.50 53.55 
46 M -0.5 51 51.5 312.61 410.55 1.19 48.38 45.00 56.50 53.55 
47 M -1 52.5 53.5 296.56 349.48 1.28 39.64 38.00 48.76 48.64 
48 M -1 52.5 53.5 296.56 406.91 1.28 26.36 25.00 32.43 32.00 
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Bladder organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 0.78 0.77 0.98 0.99 
2 M 21.5 51 29.5 322.24 430.25 1.14 1.10 1.00 1.24 1.14 
3 F 1.5 36.5 35 221.01 124.68 1.65 8.23 6.50 12.75 10.73 
4 F 1.5 36.5 35 221.01 124.95 1.65 8.24 6.50 12.77 10.73 
5 F 0.5 38 37.5 251.35 203.64 1.48 26.67 23.00 39.43 34.04 
6 F 3.5 41 37.5 251.35 203.64 1.48 25.54 21.00 37.78 31.08 
7 M 0.5 39.5 39 257.16 344.87 1.48 19.85 18.00 28.86 26.64 
8 F 2.5 42.5 40 247.69 229.31 1.53 30.45 25.00 47.18 38.25 
9 F 3 43 40 247.69 242.53 1.53 33.43 26.00 51.75 39.78 
10 M -1 39.5 40.5 264.81 424.69 1.43 21.54 23.00 31.20 32.89 
11 M -1 39.5 40.5 264.81 424.99 1.43 21.58 23.00 31.26 32.89 
12 F -1 39.5 40.5 278.83 494.60 1.37 31.36 27.00 41.41 36.99 
13 F -1 39.5 40.5 278.83 497.70 1.37 32.14 27.00 42.44 36.99 
14 F 2.5 43.5 41 250.71 227.20 1.48 14.22 11.00 20.42 16.28 
15 F 4 45.5 41.5 229.62 193.39 1.65 12.98 9.30 19.42 15.35 
16 F -0.5 41.5 42 229.75 193.24 1.65 13.71 10.00 20.68 16.50 
17 F 3.5 45.5 42 259.45 276.61 1.48 17.18 14.00 24.16 20.72 
18 F 3.5 45.5 42 254.94 276.74 1.48 17.18 14.00 24.83 20.72 
19 M 0.2 42.2 42 254.94 295.78 1.48 19.31 16.00 28.22 23.68 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 19.38 16.00 27.82 23.68 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 23.84 21.00 32.81 30.03 
22 M -5.5 38 43.5 235.98 160.77 1.59 21.08 19.00 33.53 30.21 
23 M 3 46.5 43.5 235.98 160.77 1.59 22.10 17.00 35.13 27.03 
24 F 1 45 44 250.94 201.88 1.48 29.67 22.00 42.82 32.56 
25 F 1 45 44 250.11 273.52 1.48 20.74 17.00 30.17 25.16 
26 M 0.5 44.5 44 272.22 286.49 1.37 35.53 32.00 50.84 43.84 
27 F 1 45.5 44.5 268.07 270.89 1.43 37.14 30.00 51.05 42.90 
28 M 6.5 51 44.5 276.03 296.26 1.37 21.74 23.00 31.03 31.51 
29 M -2 42.5 44.5 282.05 297.81 1.32 46.10 41.00 63.13 54.12 
30 F 1 45.5 44.5 264.85 326.53 1.43 21.95 20.00 30.42 28.60 
31 F 2.5 47 44.5 306.76 336.28 1.23 44.28 36.00 53.66 44.28 
32 M 0 45 45 276.59 297.81 1.37 37.98 34.00 52.12 46.58 
33 M 0 45 45 276.59 297.81 1.37 37.98 34.00 52.12 46.58 
34 F 3.5 48.5 45 306.89 337.42 1.23 44.06 35.00 53.16 43.05 
35 F 1.5 48 46.5 267.80 291.40 1.43 37.42 32.00 51.41 45.76 
36 F -0.5 47 47.5 295.37 333.65 1.28 38.35 38.00 50.27 48.64 
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37 F 2 49.5 47.5 296.51 374.06 1.28 22.37 23.00 29.45 29.44 
38 M -2 47 49 275.87 306.99 1.37 38.64 36.00 52.54 49.32 
39 M 1 50 49 271.62 309.13 1.37 37.39 34.00 51.51 46.58 
40 M -5.5 43.5 49 290.19 317.92 1.28 40.70 38.00 53.66 48.64 
41 M -5.5 43.5 49 291.48 317.92 1.28 40.70 38.00 53.42 48.64 
42 M -2 47 49 295.09 453.91 1.28 24.90 25.00 32.48 32.00 
43 M -2 47 49 295.09 455.87 1.28 24.98 25.00 32.58 32.00 
44 M -6 44 50 262.67 268.34 1.43 38.76 32.00 55.44 45.76 
45 M -0.5 51 51.5 312.61 410.55 1.19 43.69 47.00 55.87 55.93 
46 M -0.5 51 51.5 312.61 410.55 1.19 43.69 47.00 55.87 55.93 
47 M -1 52.5 53.5 296.56 349.48 1.28 39.67 40.00 52.75 51.20 
48 M -1 52.5 53.5 296.56 406.91 1.28 25.66 26.00 34.11 33.28 
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Breast organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 1.26 1.30 1.62 1.66 
2 M 21.5 51 29.5 322.24 430.25 1.14 13.64 14.00 15.87 15.96 
3 F 1.5 36.5 35 221.01 124.68 1.65 0.04 0.05 0.07 0.09 
4 F 1.5 36.5 35 221.01 124.95 1.65 0.04 0.05 0.07 0.09 
5 F 0.5 38 37.5 251.35 203.64 1.48 0.19 0.24 0.29 0.36 
6 F 3.5 41 37.5 251.35 203.64 1.48 0.32 0.40 0.48 0.59 
7 M 0.5 39.5 39 257.16 344.87 1.48 0.26 0.25 0.36 0.37 
8 F 2.5 42.5 40 247.69 229.31 1.53 0.46 0.60 0.69 0.92 
9 F 3 43 40 247.69 242.53 1.53 0.53 0.69 0.79 1.06 
10 M -1 39.5 40.5 264.81 424.69 1.43 0.36 0.30 0.50 0.43 
11 M -1 39.5 40.5 264.81 424.99 1.43 0.36 0.30 0.50 0.43 
12 F -1 39.5 40.5 278.83 494.60 1.37 0.31 0.35 0.42 0.48 
13 F -1 39.5 40.5 278.83 497.70 1.37 0.31 0.36 0.42 0.49 
14 F 2.5 43.5 41 250.71 227.20 1.48 0.28 0.34 0.41 0.50 
15 F 4 45.5 41.5 229.62 193.39 1.65 0.30 0.41 0.48 0.68 
16 F -0.5 41.5 42 229.75 193.24 1.65 0.15 0.20 0.24 0.33 
17 F 3.5 45.5 42 259.45 276.61 1.48 0.50 0.58 0.73 0.86 
18 F 3.5 45.5 42 254.94 276.74 1.48 0.50 0.58 0.70 0.86 
19 M 0.2 42.2 42 254.94 295.78 1.48 0.30 0.34 0.43 0.50 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 0.33 0.38 0.49 0.56 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 0.55 0.64 0.78 0.92 
22 M -5.5 38 43.5 235.98 160.77 1.59 0.16 0.19 0.24 0.30 
23 M 3 46.5 43.5 235.98 160.77 1.59 0.68 0.86 1.03 1.37 
24 F 1 45 44 250.94 201.88 1.48 0.66 0.82 0.98 1.21 
25 F 1 45 44 250.11 273.52 1.48 0.52 0.62 0.77 0.92 
26 M 0.5 44.5 44 272.22 286.49 1.37 0.79 1.10 1.05 1.51 
27 F 1 45.5 44.5 268.07 270.89 1.43 0.84 1.20 1.19 1.72 
28 M 6.5 51 44.5 276.03 296.26 1.37 9.42 9.40 12.45 12.88 
29 M -2 42.5 44.5 282.05 297.81 1.32 0.68 0.93 0.87 1.23 
30 F 1 45.5 44.5 264.85 326.53 1.43 0.67 0.81 0.95 1.16 
31 F 2.5 47 44.5 306.76 336.28 1.23 1.65 2.00 2.09 2.46 
32 M 0 45 45 276.59 297.81 1.37 0.89 1.20 1.20 1.64 
33 M 0 45 45 276.59 297.81 1.37 0.89 1.20 1.20 1.64 
34 F 3.5 48.5 45 306.89 337.42 1.23 2.40 2.80 3.03 3.44 
35 F 1.5 48 46.5 267.80 291.40 1.43 1.47 2.10 2.09 3.00 
36 F -0.5 47 47.5 295.37 333.65 1.28 1.98 2.00 2.46 2.56 
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37 F 2 49.5 47.5 296.51 374.06 1.28 3.11 3.10 3.85 3.97 
38 M -2 47 49 275.87 306.99 1.37 1.62 1.80 2.15 2.47 
39 M 1 50 49 271.62 309.13 1.37 5.42 6.10 7.00 8.36 
40 M -5.5 43.5 49 290.19 317.92 1.28 0.72 1.00 0.90 1.28 
41 M -5.5 43.5 49 291.48 317.92 1.28 0.72 1.00 0.90 1.28 
42 M -2 47 49 295.09 453.91 1.28 1.28 1.30 1.64 1.66 
43 M -2 47 49 295.09 455.87 1.28 1.28 1.30 1.63 1.66 
44 M -6 44 50 262.67 268.34 1.43 0.62 0.93 0.87 1.33 
45 M -0.5 51 51.5 312.61 410.55 1.19 13.67 13.00 15.91 15.47 
46 M -0.5 51 51.5 312.61 410.55 1.19 13.67 13.00 15.91 15.47 
47 M -1 52.5 53.5 296.56 349.48 1.28 19.55 18.00 23.32 23.04 
48 M -1 52.5 53.5 296.56 406.91 1.28 11.56 12.00 13.80 15.36 
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Liver organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-
Size 
Slice 
mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 22.59 21.00 28.90 26.88 
2 M 21.5 51 29.5 322.24 430.25 1.14 44.79 44.00 52.54 50.16 
3 F 1.5 36.5 35 221.01 124.68 1.65 2.00 2.70 3.48 4.46 
4 F 1.5 36.5 35 221.01 124.95 1.65 2.00 2.70 3.48 4.46 
5 F 0.5 38 37.5 251.35 203.64 1.48 9.47 12.00 14.23 17.76 
6 F 3.5 41 37.5 251.35 203.64 1.48 13.35 16.00 20.12 23.68 
7 M 0.5 39.5 39 257.16 344.87 1.48 11.68 11.00 16.32 16.28 
8 F 2.5 42.5 40 247.69 229.31 1.53 17.21 20.00 25.63 30.60 
9 F 3 43 40 247.69 242.53 1.53 19.03 22.00 28.35 33.66 
10 M -1 39.5 40.5 264.81 424.69 1.43 16.31 13.00 22.29 18.59 
11 M -1 39.5 40.5 264.81 424.99 1.43 16.31 13.00 22.29 18.59 
12 F -1 39.5 40.5 278.83 494.60 1.37 13.60 16.00 18.29 21.92 
13 F -1 39.5 40.5 278.83 497.70 1.37 13.59 16.00 18.29 21.92 
14 F 2.5 43.5 41 250.71 227.20 1.48 8.49 9.90 12.78 14.65 
15 F 4 45.5 41.5 229.62 193.39 1.65 6.81 8.80 11.31 14.52 
16 F -0.5 41.5 42 229.75 193.24 1.65 5.55 7.40 9.09 12.21 
17 F 3.5 45.5 42 259.45 276.61 1.48 10.97 13.00 16.21 19.24 
18 F 3.5 45.5 42 254.94 276.74 1.48 10.97 13.00 16.15 19.24 
19 M 0.2 42.2 42 254.94 295.78 1.48 10.91 12.00 15.69 17.76 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 11.31 12.00 16.94 17.76 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 16.35 18.00 23.55 25.74 
22 M -5.5 38 43.5 235.98 160.77 1.59 7.52 9.10 11.36 14.47 
23 M 3 46.5 43.5 235.98 160.77 1.59 14.55 16.00 22.76 25.44 
24 F 1 45 44 250.94 201.88 1.48 15.71 19.00 23.76 28.12 
25 F 1 45 44 250.11 273.52 1.48 12.27 15.00 18.59 22.20 
26 M 0.5 44.5 44 272.22 286.49 1.37 24.56 27.00 33.07 36.99 
27 F 1 45.5 44.5 268.07 270.89 1.43 22.44 26.00 31.91 37.18 
28 M 6.5 51 44.5 276.03 296.26 1.37 31.07 30.00 41.58 41.10 
29 M -2 42.5 44.5 282.05 297.81 1.32 25.78 31.00 33.47 40.92 
30 F 1 45.5 44.5 264.85 326.53 1.43 16.93 18.00 24.34 25.74 
31 F 2.5 47 44.5 306.76 336.28 1.23 29.79 33.00 37.93 40.59 
32 M 0 45 45 276.59 297.81 1.37 24.51 29.00 33.30 39.73 
33 M 0 45 45 276.59 297.81 1.37 24.51 29.00 33.30 39.73 
34 F 3.5 48.5 45 306.89 337.42 1.23 30.87 34.00 39.15 41.82 
35 F 1.5 48 46.5 267.80 291.40 1.43 25.38 29.00 36.68 41.47 
36 F -0.5 47 47.5 295.37 333.65 1.28 33.55 33.00 42.48 42.24 
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37 F 2 49.5 47.5 296.51 374.06 1.28 21.62 21.00 27.33 26.88 
38 M -2 47 49 275.87 306.99 1.37 30.60 30.00 41.36 41.10 
39 M 1 50 49 271.62 309.13 1.37 31.99 32.00 43.57 43.84 
40 M -5.5 43.5 49 290.19 317.92 1.28 25.04 30.00 31.82 38.40 
41 M -5.5 43.5 49 291.48 317.92 1.28 25.04 30.00 31.53 38.40 
42 M -2 47 49 295.09 453.91 1.28 22.77 21.00 29.13 26.88 
43 M -2 47 49 295.09 455.87 1.28 22.78 21.00 29.14 26.88 
44 M -6 44 50 262.67 268.34 1.43 19.85 25.00 28.20 35.75 
45 M -0.5 51 51.5 312.61 410.55 1.19 45.37 42.00 53.22 49.98 
46 M -0.5 51 51.5 312.61 410.55 1.19 45.37 42.00 53.22 49.98 
47 M -1 52.5 53.5 296.56 349.48 1.28 37.60 36.00 46.17 46.08 
48 M -1 52.5 53.5 296.56 406.91 1.28 24.85 24.00 30.51 30.72 
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Skin organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 4.42 4.30 5.62 5.50 
2 M 21.5 51 29.5 322.24 430.25 1.14 9.53 9.40 11.03 10.72 
3 F 1.5 36.5 35 221.01 124.68 1.65 1.56 1.50 2.57 2.48 
4 F 1.5 36.5 35 221.01 124.95 1.65 1.56 1.50 2.58 2.48 
5 F 0.5 38 37.5 251.35 203.64 1.48 5.80 5.70 8.68 8.44 
6 F 3.5 41 37.5 251.35 203.64 1.48 5.73 5.60 8.57 8.29 
7 M 0.5 39.5 39 257.16 344.87 1.48 4.79 4.70 6.97 6.96 
8 F 2.5 42.5 40 247.69 229.31 1.53 6.89 6.80 10.50 10.40 
9 F 3 43 40 247.69 242.53 1.53 7.29 7.20 11.10 11.02 
10 M -1 39.5 40.5 264.81 424.69 1.43 6.18 6.10 8.78 8.72 
11 M -1 39.5 40.5 264.81 424.99 1.43 6.19 6.10 8.79 8.72 
12 F -1 39.5 40.5 278.83 494.60 1.37 7.25 7.10 9.74 9.73 
13 F -1 39.5 40.5 278.83 497.70 1.37 7.30 7.10 9.80 9.73 
14 F 2.5 43.5 41 250.71 227.20 1.48 3.28 3.20 4.90 4.74 
15 F 4 45.5 41.5 229.62 193.39 1.65 2.82 2.80 4.51 4.62 
16 F -0.5 41.5 42 229.75 193.24 1.65 2.93 2.90 4.67 4.79 
17 F 3.5 45.5 42 259.45 276.61 1.48 4.08 4.00 5.91 5.92 
18 F 3.5 45.5 42 254.94 276.74 1.48 4.09 4.00 6.05 5.92 
19 M 0.2 42.2 42 254.94 295.78 1.48 4.43 4.30 6.54 6.36 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 4.41 4.40 6.56 6.51 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 6.16 6.10 8.67 8.72 
22 M -5.5 38 43.5 235.98 160.77 1.59 5.68 5.50 9.03 8.75 
23 M 3 46.5 43.5 235.98 160.77 1.59 5.24 5.20 8.33 8.27 
24 F 1 45 44 250.94 201.88 1.48 6.70 6.60 9.99 9.77 
25 F 1 45 44 250.11 273.52 1.48 5.06 5.00 7.57 7.40 
26 M 0.5 44.5 44 272.22 286.49 1.37 9.51 9.30 13.26 12.74 
27 F 1 45.5 44.5 268.07 270.89 1.43 9.09 8.90 12.75 12.73 
28 M 6.5 51 44.5 276.03 296.26 1.37 9.85 9.70 13.49 13.29 
29 M -2 42.5 44.5 282.05 297.81 1.32 12.28 12.00 16.54 15.84 
30 F 1 45.5 44.5 264.85 326.53 1.43 6.09 6.00 8.70 8.58 
31 F 2.5 47 44.5 306.76 336.28 1.23 11.23 11.00 13.72 13.53 
32 M 0 45 45 276.59 297.81 1.37 10.14 10.00 13.86 13.70 
33 M 0 45 45 276.59 297.81 1.37 10.14 10.00 13.86 13.70 
34 F 3.5 48.5 45 306.89 337.42 1.23 11.38 11.00 13.90 13.53 
35 F 1.5 48 46.5 267.80 291.40 1.43 10.17 10.00 14.29 14.30 
36 F -0.5 47 47.5 295.37 333.65 1.28 12.00 12.00 15.28 15.36 
37 F 2 49.5 47.5 296.51 374.06 1.28 7.44 7.40 9.44 9.47 
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38 M -2 47 49 275.87 306.99 1.37 11.55 11.00 15.78 15.07 
39 M 1 50 49 271.62 309.13 1.37 11.41 11.00 15.85 15.07 
40 M -5.5 43.5 49 290.19 317.92 1.28 12.38 12.00 16.22 15.36 
41 M -5.5 43.5 49 291.48 317.92 1.28 12.38 12.00 16.10 15.36 
42 M -2 47 49 295.09 453.91 1.28 7.99 7.90 10.24 10.11 
43 M -2 47 49 295.09 455.87 1.28 8.02 7.90 10.29 10.11 
44 M -6 44 50 262.67 268.34 1.43 10.79 10.00 15.52 14.30 
45 M -0.5 51 51.5 312.61 410.55 1.19 16.04 16.00 19.23 19.04 
46 M -0.5 51 51.5 312.61 410.55 1.19 16.04 16.00 19.23 19.04 
47 M -1 52.5 53.5 296.56 349.48 1.28 14.27 14.00 18.11 17.92 
48 M -1 52.5 53.5 296.56 406.91 1.28 9.25 9.10 11.74 11.65 
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Bone Surface organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 8.93 8.70 11.36 11.14 
2 M 21.5 51 29.5 322.24 430.25 1.14 19.93 19.00 23.16 21.66 
3 F 1.5 36.5 35 221.01 124.68 1.65 2.52 2.50 4.20 4.13 
4 F 1.5 36.5 35 221.01 124.95 1.65 2.53 2.50 4.22 4.13 
5 F 0.5 38 37.5 251.35 203.64 1.48 9.42 9.40 14.09 13.91 
6 F 3.5 41 37.5 251.35 203.64 1.48 9.92 9.80 14.79 14.50 
7 M 0.5 39.5 39 257.16 344.87 1.48 8.01 8.00 11.63 11.84 
8 F 2.5 42.5 40 247.69 229.31 1.53 12.05 12.00 18.27 18.36 
9 F 3 43 40 247.69 242.53 1.53 12.71 13.00 19.26 19.89 
10 M -1 39.5 40.5 264.81 424.69 1.43 10.29 10.00 14.57 14.30 
11 M -1 39.5 40.5 264.81 424.99 1.43 10.30 10.00 14.58 14.30 
12 F -1 39.5 40.5 278.83 494.60 1.37 11.86 12.00 15.96 16.44 
13 F -1 39.5 40.5 278.83 497.70 1.37 11.91 12.00 16.03 16.44 
14 F 2.5 43.5 41 250.71 227.20 1.48 5.74 5.80 8.56 8.58 
15 F 4 45.5 41.5 229.62 193.39 1.65 5.05 5.10 8.08 8.42 
16 F -0.5 41.5 42 229.75 193.24 1.65 4.82 4.90 7.76 8.09 
17 F 3.5 45.5 42 259.45 276.61 1.48 7.37 7.40 10.68 10.95 
18 F 3.5 45.5 42 254.94 276.74 1.48 7.37 7.40 10.86 10.95 
19 M 0.2 42.2 42 254.94 295.78 1.48 7.47 7.60 11.00 11.25 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 7.50 7.70 11.14 11.40 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 10.82 11.00 15.25 15.73 
22 M -5.5 38 43.5 235.98 160.77 1.59 8.87 8.80 14.15 13.99 
23 M 3 46.5 43.5 235.98 160.77 1.59 9.54 9.50 15.07 15.11 
24 F 1 45 44 250.94 201.88 1.48 11.95 12.00 17.81 17.76 
25 F 1 45 44 250.11 273.52 1.48 9.10 9.00 13.61 13.32 
26 M 0.5 44.5 44 272.22 286.49 1.37 16.49 17.00 22.90 23.29 
27 F 1 45.5 44.5 268.07 270.89 1.43 16.09 16.00 22.66 22.88 
28 M 6.5 51 44.5 276.03 296.26 1.37 19.94 19.00 27.18 26.03 
29 M -2 42.5 44.5 282.05 297.81 1.32 20.46 21.00 27.49 27.72 
30 F 1 45.5 44.5 264.85 326.53 1.43 10.89 11.00 15.57 15.73 
31 F 2.5 47 44.5 306.76 336.28 1.23 20.35 21.00 24.96 25.83 
32 M 0 45 45 276.59 297.81 1.37 17.74 18.00 24.20 24.66 
33 M 0 45 45 276.59 297.81 1.37 17.74 18.00 24.20 24.66 
34 F 3.5 48.5 45 306.89 337.42 1.23 20.98 21.00 25.80 25.83 
35 F 1.5 48 46.5 267.80 291.40 1.43 18.40 19.00 25.91 27.17 
36 F -0.5 47 47.5 295.37 333.65 1.28 22.00 22.00 27.88 28.16 
37 F 2 49.5 47.5 296.51 374.06 1.28 14.19 14.00 17.94 17.92 
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38 M -2 47 49 275.87 306.99 1.37 20.73 20.00 28.21 27.40 
39 M 1 50 49 271.62 309.13 1.37 21.60 21.00 29.86 28.77 
40 M -5.5 43.5 49 290.19 317.92 1.28 20.71 21.00 27.01 26.88 
41 M -5.5 43.5 49 291.48 317.92 1.28 20.71 21.00 26.83 26.88 
42 M -2 47 49 295.09 453.91 1.28 14.43 14.00 18.43 17.92 
43 M -2 47 49 295.09 455.87 1.28 14.50 14.00 18.53 17.92 
44 M -6 44 50 262.67 268.34 1.43 17.92 18.00 25.78 25.74 
45 M -0.5 51 51.5 312.61 410.55 1.19 30.72 30.00 36.52 35.70 
46 M -0.5 51 51.5 312.61 410.55 1.19 30.72 30.00 36.52 35.70 
47 M -1 52.5 53.5 296.56 349.48 1.28 27.49 27.00 34.61 34.56 
48 M -1 52.5 53.5 296.56 406.91 1.28 17.76 17.00 22.37 21.76 
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Adrenals organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 22.11 21.00 28.29 26.88 
2 M 21.5 51 29.5 322.24 430.25 1.14 43.95 43.00 51.96 49.02 
3 F 1.5 36.5 35 221.01 124.68 1.65 0.71 0.96 1.23 1.58 
4 F 1.5 36.5 35 221.01 124.95 1.65 0.71 0.96 1.23 1.58 
5 F 0.5 38 37.5 251.35 203.64 1.48 3.68 5.00 5.51 7.40 
6 F 3.5 41 37.5 251.35 203.64 1.48 9.65 14.00 14.39 20.72 
7 M 0.5 39.5 39 257.16 344.87 1.48 8.33 7.50 11.28 11.10 
8 F 2.5 42.5 40 247.69 229.31 1.53 14.24 19.00 21.13 29.07 
9 F 3 43 40 247.69 242.53 1.53 16.21 21.00 24.04 32.13 
10 M -1 39.5 40.5 264.81 424.69 1.43 11.53 9.30 15.51 13.30 
11 M -1 39.5 40.5 264.81 424.99 1.43 11.53 9.30 15.51 13.30 
12 F -1 39.5 40.5 278.83 494.60 1.37 9.33 11.00 12.66 15.07 
13 F -1 39.5 40.5 278.83 497.70 1.37 9.33 11.00 12.66 15.07 
14 F 2.5 43.5 41 250.71 227.20 1.48 7.82 9.30 11.46 13.76 
15 F 4 45.5 41.5 229.62 193.39 1.65 6.50 8.40 10.55 13.86 
16 F -0.5 41.5 42 229.75 193.24 1.65 4.71 6.70 7.61 11.06 
17 F 3.5 45.5 42 259.45 276.61 1.48 10.47 12.00 15.47 17.76 
18 F 3.5 45.5 42 254.94 276.74 1.48 10.47 12.00 15.04 17.76 
19 M 0.2 42.2 42 254.94 295.78 1.48 9.84 11.00 13.66 16.28 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 10.37 12.00 15.11 17.76 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 14.53 17.00 20.82 24.31 
22 M -5.5 38 43.5 235.98 160.77 1.59 3.03 3.90 4.52 6.20 
23 M 3 46.5 43.5 235.98 160.77 1.59 14.14 15.00 21.65 23.85 
24 F 1 45 44 250.94 201.88 1.48 15.08 18.00 22.47 26.64 
25 F 1 45 44 250.11 273.52 1.48 11.83 14.00 17.63 20.72 
26 M 0.5 44.5 44 272.22 286.49 1.37 20.18 26.00 26.85 35.62 
27 F 1 45.5 44.5 268.07 270.89 1.43 21.18 25.00 30.14 35.75 
28 M 6.5 51 44.5 276.03 296.26 1.37 30.74 29.00 40.75 39.73 
29 M -2 42.5 44.5 282.05 297.81 1.32 18.77 29.00 23.90 38.28 
30 F 1 45.5 44.5 264.85 326.53 1.43 15.52 17.00 22.13 24.31 
31 F 2.5 47 44.5 306.76 336.28 1.23 28.35 32.00 36.31 39.36 
32 M 0 45 45 276.59 297.81 1.37 20.74 27.00 28.20 36.99 
33 M 0 45 45 276.59 297.81 1.37 20.74 27.00 28.20 36.99 
34 F 3.5 48.5 45 306.89 337.42 1.23 29.81 33.00 38.36 40.59 
35 F 1.5 48 46.5 267.80 291.40 1.43 23.13 28.00 33.79 40.04 
36 F -0.5 47 47.5 295.37 333.65 1.28 32.28 32.00 41.05 40.96 
37 F 2 49.5 47.5 296.51 374.06 1.28 21.10 21.00 26.83 26.88 
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38 M -2 47 49 275.87 306.99 1.37 29.44 29.00 39.21 39.73 
39 M 1 50 49 271.62 309.13 1.37 31.84 31.00 42.60 42.47 
40 M -5.5 43.5 49 290.19 317.92 1.28 19.31 28.00 24.18 35.84 
41 M -5.5 43.5 49 291.48 317.92 1.28 19.31 28.00 24.00 35.84 
42 M -2 47 49 295.09 453.91 1.28 22.19 20.00 28.39 25.60 
43 M -2 47 49 295.09 455.87 1.28 22.18 20.00 28.38 25.60 
44 M -6 44 50 262.67 268.34 1.43 16.17 24.00 22.64 34.32 
45 M -0.5 51 51.5 312.61 410.55 1.19 44.15 41.00 52.20 48.79 
46 M -0.5 51 51.5 312.61 410.55 1.19 44.15 41.00 52.20 48.79 
47 M -1 52.5 53.5 296.56 349.48 1.28 37.01 35.00 45.36 44.80 
48 M -1 52.5 53.5 296.56 406.91 1.28 24.30 23.00 29.79 29.44 
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Small Intestine organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 13.88 14.00 17.39 17.92 
2 M 21.5 51 29.5 322.24 430.25 1.14 23.06 22.00 26.00 25.08 
3 F 1.5 36.5 35 221.01 124.68 1.65 5.30 5.80 9.29 9.57 
4 F 1.5 36.5 35 221.01 124.95 1.65 5.32 5.80 9.34 9.57 
5 F 0.5 38 37.5 251.35 203.64 1.48 19.57 20.00 29.74 29.60 
6 F 3.5 41 37.5 251.35 203.64 1.48 20.83 20.00 31.31 29.60 
7 M 0.5 39.5 39 257.16 344.87 1.48 13.71 16.00 20.84 23.68 
8 F 2.5 42.5 40 247.69 229.31 1.53 22.47 23.00 34.63 35.19 
9 F 3 43 40 247.69 242.53 1.53 22.37 24.00 34.37 36.72 
10 M -1 39.5 40.5 264.81 424.69 1.43 17.64 20.00 25.19 28.60 
11 M -1 39.5 40.5 264.81 424.99 1.43 17.64 20.00 25.20 28.60 
12 F -1 39.5 40.5 278.83 494.60 1.37 20.61 23.00 28.57 31.51 
13 F -1 39.5 40.5 278.83 497.70 1.37 20.60 24.00 28.56 32.88 
14 F 2.5 43.5 41 250.71 227.20 1.48 10.51 11.00 16.24 16.28 
15 F 4 45.5 41.5 229.62 193.39 1.65 9.27 9.10 15.35 15.02 
16 F -0.5 41.5 42 229.75 193.24 1.65 8.15 9.10 13.96 15.02 
17 F 3.5 45.5 42 259.45 276.61 1.48 12.64 13.00 18.52 19.24 
18 F 3.5 45.5 42 254.94 276.74 1.48 12.65 13.00 19.34 19.24 
19 M 0.2 42.2 42 254.94 295.78 1.48 11.64 14.00 17.98 20.72 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 11.70 14.00 18.17 20.72 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 19.95 19.00 28.17 27.17 
22 M -5.5 38 43.5 235.98 160.77 1.59 14.45 16.00 23.59 25.44 
23 M 3 46.5 43.5 235.98 160.77 1.59 15.76 16.00 25.69 25.44 
24 F 1 45 44 250.94 201.88 1.48 19.85 20.00 30.24 29.60 
25 F 1 45 44 250.11 273.52 1.48 15.72 15.00 23.95 22.20 
26 M 0.5 44.5 44 272.22 286.49 1.37 30.63 29.00 42.56 39.73 
27 F 1 45.5 44.5 268.07 270.89 1.43 28.28 27.00 40.21 38.61 
28 M 6.5 51 44.5 276.03 296.26 1.37 31.25 29.00 43.49 39.73 
29 M -2 42.5 44.5 282.05 297.81 1.32 38.17 36.00 51.86 47.52 
30 F 1 45.5 44.5 264.85 326.53 1.43 19.13 18.00 27.97 25.74 
31 F 2.5 47 44.5 306.76 336.28 1.23 34.37 34.00 40.41 41.82 
32 M 0 45 45 276.59 297.81 1.37 32.40 30.00 43.83 41.10 
33 M 0 45 45 276.59 297.81 1.37 32.40 30.00 43.83 41.10 
34 F 3.5 48.5 45 306.89 337.42 1.23 34.64 34.00 40.80 41.82 
35 F 1.5 48 46.5 267.80 291.40 1.43 33.36 29.00 46.58 41.47 
36 F -0.5 47 47.5 295.37 333.65 1.28 34.41 34.00 42.68 43.52 
37 F 2 49.5 47.5 296.51 374.06 1.28 22.07 21.00 27.38 26.88 
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38 M -2 47 49 275.87 306.99 1.37 29.93 31.00 41.69 42.47 
39 M 1 50 49 271.62 309.13 1.37 32.04 31.00 47.08 42.47 
40 M -5.5 43.5 49 290.19 317.92 1.28 34.05 32.00 44.08 40.96 
41 M -5.5 43.5 49 291.48 317.92 1.28 34.05 32.00 43.82 40.96 
42 M -2 47 49 295.09 453.91 1.28 20.05 22.00 25.11 28.16 
43 M -2 47 49 295.09 455.87 1.28 20.24 22.00 25.35 28.16 
44 M -6 44 50 262.67 268.34 1.43 25.28 27.00 37.12 38.61 
45 M -0.5 51 51.5 312.61 410.55 1.19 41.76 42.00 47.86 49.98 
46 M -0.5 51 51.5 312.61 410.55 1.19 41.76 42.00 47.86 49.98 
47 M -1 52.5 53.5 296.56 349.48 1.28 34.85 35.00 44.57 44.80 
48 M -1 52.5 53.5 296.56 406.91 1.28 22.87 23.00 29.24 29.44 
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Kidney organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 26.28 25.00 33.60 32.00 
2 M 21.5 51 29.5 322.24 430.25 1.14 51.39 50.00 59.57 57.00 
3 F 1.5 36.5 35 221.01 124.68 1.65 4.32 6.00 7.52 9.90 
4 F 1.5 36.5 35 221.01 124.95 1.65 4.32 6.00 7.52 9.90 
5 F 0.5 38 37.5 251.35 203.64 1.48 19.98 22.00 30.10 32.56 
6 F 3.5 41 37.5 251.35 203.64 1.48 21.77 23.00 33.07 34.04 
7 M 0.5 39.5 39 257.16 344.87 1.48 19.12 18.00 27.33 26.64 
8 F 2.5 42.5 40 247.69 229.31 1.53 25.25 27.00 37.71 41.31 
9 F 3 43 40 247.69 242.53 1.53 27.14 28.00 40.58 42.84 
10 M -1 39.5 40.5 264.81 424.69 1.43 26.92 22.00 37.05 31.46 
11 M -1 39.5 40.5 264.81 424.99 1.43 26.91 22.00 37.04 31.46 
12 F -1 39.5 40.5 278.83 494.60 1.37 22.80 26.00 30.45 35.62 
13 F -1 39.5 40.5 278.83 497.70 1.37 22.78 26.00 30.44 35.62 
14 F 2.5 43.5 41 250.71 227.20 1.48 10.83 12.00 16.87 17.76 
15 F 4 45.5 41.5 229.62 193.39 1.65 8.20 11.00 13.99 18.15 
16 F -0.5 41.5 42 229.75 193.24 1.65 8.14 10.00 13.53 16.50 
17 F 3.5 45.5 42 259.45 276.61 1.48 13.21 15.00 19.54 22.20 
18 F 3.5 45.5 42 254.94 276.74 1.48 13.21 15.00 20.12 22.20 
19 M 0.2 42.2 42 254.94 295.78 1.48 14.90 16.00 22.17 23.68 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 14.87 16.00 22.96 23.68 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 21.73 23.00 31.46 32.89 
22 M -5.5 38 43.5 235.98 160.77 1.59 15.50 18.00 23.56 28.62 
23 M 3 46.5 43.5 235.98 160.77 1.59 17.36 19.00 28.02 30.21 
24 F 1 45 44 250.94 201.88 1.48 18.91 24.00 29.24 35.52 
25 F 1 45 44 250.11 273.52 1.48 14.74 18.00 22.84 26.64 
26 M 0.5 44.5 44 272.22 286.49 1.37 35.43 34.00 48.26 46.58 
27 F 1 45.5 44.5 268.07 270.89 1.43 28.34 32.00 40.38 45.76 
28 M 6.5 51 44.5 276.03 296.26 1.37 34.87 35.00 47.35 47.95 
29 M -2 42.5 44.5 282.05 297.81 1.32 41.66 42.00 54.85 55.44 
30 F 1 45.5 44.5 264.85 326.53 1.43 21.94 21.00 31.91 30.03 
31 F 2.5 47 44.5 306.76 336.28 1.23 36.59 40.00 46.14 49.20 
32 M 0 45 45 276.59 297.81 1.37 34.39 35.00 46.73 47.95 
33 M 0 45 45 276.59 297.81 1.37 34.39 35.00 46.73 47.95 
34 F 3.5 48.5 45 306.89 337.42 1.23 37.36 40.00 46.49 49.20 
35 F 1.5 48 46.5 267.80 291.40 1.43 32.85 35.00 47.02 50.05 
36 F -0.5 47 47.5 295.37 333.65 1.28 40.05 40.00 50.43 51.20 
37 F 2 49.5 47.5 296.51 374.06 1.28 24.99 25.00 31.34 32.00 
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38 M -2 47 49 275.87 306.99 1.37 37.44 36.00 51.50 49.32 
39 M 1 50 49 271.62 309.13 1.37 35.92 37.00 50.31 50.69 
40 M -5.5 43.5 49 290.19 317.92 1.28 37.79 37.00 48.51 47.36 
41 M -5.5 43.5 49 291.48 317.92 1.28 37.79 37.00 48.13 47.36 
42 M -2 47 49 295.09 453.91 1.28 26.62 25.00 34.03 32.00 
43 M -2 47 49 295.09 455.87 1.28 26.65 25.00 34.07 32.00 
44 M -6 44 50 262.67 268.34 1.43 28.70 31.00 41.24 44.33 
45 M -0.5 51 51.5 312.61 410.55 1.19 52.47 49.00 60.84 58.31 
46 M -0.5 51 51.5 312.61 410.55 1.19 52.47 49.00 60.84 58.31 
47 M -1 52.5 53.5 296.56 349.48 1.28 42.39 42.00 52.21 53.76 
48 M -1 52.5 53.5 296.56 406.91 1.28 28.39 27.00 34.97 34.56 
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Pancreas organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 20.82 19.00 26.63 24.32 
2 M 21.5 51 29.5 322.24 430.25 1.14 40.96 40.00 48.24 45.60 
3 F 1.5 36.5 35 221.01 124.68 1.65 1.57 2.10 2.72 3.47 
4 F 1.5 36.5 35 221.01 124.95 1.65 1.57 2.10 2.72 3.47 
5 F 0.5 38 37.5 251.35 203.64 1.48 7.94 11.00 11.88 16.28 
6 F 3.5 41 37.5 251.35 203.64 1.48 13.07 16.00 19.59 23.68 
7 M 0.5 39.5 39 257.16 344.87 1.48 12.07 11.00 16.56 16.28 
8 F 2.5 42.5 40 247.69 229.31 1.53 16.49 19.00 24.52 29.07 
9 F 3 43 40 247.69 242.53 1.53 18.06 20.00 26.86 30.60 
10 M -1 39.5 40.5 264.81 424.69 1.43 16.75 14.00 22.76 20.02 
11 M -1 39.5 40.5 264.81 424.99 1.43 16.75 14.00 22.75 20.02 
12 F -1 39.5 40.5 278.83 494.60 1.37 13.78 16.00 18.62 21.92 
13 F -1 39.5 40.5 278.83 497.70 1.37 13.77 16.00 18.62 21.92 
14 F 2.5 43.5 41 250.71 227.20 1.48 7.92 9.00 11.81 13.32 
15 F 4 45.5 41.5 229.62 193.39 1.65 6.32 8.00 10.45 13.20 
16 F -0.5 41.5 42 229.75 193.24 1.65 5.37 7.10 8.70 11.72 
17 F 3.5 45.5 42 259.45 276.61 1.48 10.06 12.00 14.87 17.76 
18 F 3.5 45.5 42 254.94 276.74 1.48 10.06 12.00 14.80 17.76 
19 M 0.2 42.2 42 254.94 295.78 1.48 10.44 11.00 14.92 16.28 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 10.68 11.00 15.85 16.28 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 14.97 16.00 21.70 22.88 
22 M -5.5 38 43.5 235.98 160.77 1.59 6.49 8.60 9.70 13.67 
23 M 3 46.5 43.5 235.98 160.77 1.59 13.90 14.00 21.60 22.26 
24 F 1 45 44 250.94 201.88 1.48 14.59 18.00 21.95 26.64 
25 F 1 45 44 250.11 273.52 1.48 11.40 13.00 17.16 19.24 
26 M 0.5 44.5 44 272.22 286.49 1.37 22.81 25.00 30.58 34.25 
27 F 1 45.5 44.5 268.07 270.89 1.43 21.34 24.00 30.23 34.32 
28 M 6.5 51 44.5 276.03 296.26 1.37 28.62 28.00 38.18 38.36 
29 M -2 42.5 44.5 282.05 297.81 1.32 22.74 29.00 29.46 38.28 
30 F 1 45.5 44.5 264.85 326.53 1.43 15.69 16.00 22.51 22.88 
31 F 2.5 47 44.5 306.76 336.28 1.23 27.54 30.00 35.32 36.90 
32 M 0 45 45 276.59 297.81 1.37 22.62 26.00 30.83 35.62 
33 M 0 45 45 276.59 297.81 1.37 22.62 26.00 30.83 35.62 
34 F 3.5 48.5 45 306.89 337.42 1.23 27.98 31.00 35.84 38.13 
35 F 1.5 48 46.5 267.80 291.40 1.43 23.26 27.00 33.70 38.61 
36 F -0.5 47 47.5 295.37 333.65 1.28 30.58 30.00 38.83 38.40 
37 F 2 49.5 47.5 296.51 374.06 1.28 19.73 19.00 25.01 24.32 
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38 M -2 47 49 275.87 306.99 1.37 28.56 28.00 38.46 38.36 
39 M 1 50 49 271.62 309.13 1.37 29.64 29.00 40.33 39.73 
40 M -5.5 43.5 49 290.19 317.92 1.28 23.27 27.00 29.54 34.56 
41 M -5.5 43.5 49 291.48 317.92 1.28 23.27 27.00 29.17 34.56 
42 M -2 47 49 295.09 453.91 1.28 21.00 19.00 26.85 24.32 
43 M -2 47 49 295.09 455.87 1.28 21.00 19.00 26.86 24.32 
44 M -6 44 50 262.67 268.34 1.43 18.43 23.00 26.18 32.89 
45 M -0.5 51 51.5 312.61 410.55 1.19 41.48 39.00 48.85 46.41 
46 M -0.5 51 51.5 312.61 410.55 1.19 41.48 39.00 48.85 46.41 
47 M -1 52.5 53.5 296.56 349.48 1.28 34.33 33.00 42.13 42.24 
48 M -1 52.5 53.5 296.56 406.91 1.28 22.72 22.00 27.90 28.16 
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Uterus organ dose data 
  
Sex Start End 
Scan 
Length 
cm 
Avg 
Size 
Avg 
Current 
Global 
SSDE 
Non-Size 
Slice mA 
Method 
NAOD SSOD SAOD 
1 M 19.5 47 27.5 297.57 459.34 1.28 1.85 1.80 2.31 2.30 
2 M 21.5 51 29.5 322.24 430.25 1.14 2.60 2.40 2.93 2.74 
3 F 1.5 36.5 35 221.01 124.68 1.65 7.53 6.20 11.95 10.23 
4 F 1.5 36.5 35 221.01 124.95 1.65 7.55 6.20 11.98 10.23 
5 F 0.5 38 37.5 251.35 203.64 1.48 24.85 22.00 36.61 32.56 
6 F 3.5 41 37.5 251.35 203.64 1.48 24.21 21.00 35.78 31.08 
7 M 0.5 39.5 39 257.16 344.87 1.48 17.94 17.00 26.14 25.16 
8 F 2.5 42.5 40 247.69 229.31 1.53 28.82 24.00 44.21 36.72 
9 F 3 43 40 247.69 242.53 1.53 30.90 25.00 47.46 38.25 
10 M -1 39.5 40.5 264.81 424.69 1.43 19.46 22.00 28.12 31.46 
11 M -1 39.5 40.5 264.81 424.99 1.43 19.49 22.00 28.16 31.46 
12 F -1 39.5 40.5 278.83 494.60 1.37 28.31 25.00 37.32 34.25 
13 F -1 39.5 40.5 278.83 497.70 1.37 28.72 26.00 37.87 35.62 
14 F 2.5 43.5 41 250.71 227.20 1.48 13.20 11.00 19.08 16.28 
15 F 4 45.5 41.5 229.62 193.39 1.65 12.23 9.20 18.45 15.18 
16 F -0.5 41.5 42 229.75 193.24 1.65 11.95 9.90 18.38 16.34 
17 F 3.5 45.5 42 259.45 276.61 1.48 16.17 13.00 22.68 19.24 
18 F 3.5 45.5 42 254.94 276.74 1.48 16.18 13.00 23.64 19.24 
19 M 0.2 42.2 42 254.94 295.78 1.48 16.85 15.00 24.83 22.20 
20 M 0.2 42.7 42.5 250.99 295.39 1.48 16.97 15.00 24.53 22.20 
21 F 1.3 43.8 42.5 267.58 345.29 1.43 22.60 20.00 31.25 28.60 
22 M -5.5 38 43.5 235.98 160.77 1.59 18.36 18.00 29.56 28.62 
23 M 3 46.5 43.5 235.98 160.77 1.59 20.61 17.00 32.67 27.03 
24 F 1 45 44 250.94 201.88 1.48 27.43 22.00 39.92 32.56 
25 F 1 45 44 250.11 273.52 1.48 19.62 16.00 28.78 23.68 
26 M 0.5 44.5 44 272.22 286.49 1.37 33.15 31.00 47.31 42.47 
27 F 1 45.5 44.5 268.07 270.89 1.43 35.06 29.00 48.42 41.47 
28 M 6.5 51 44.5 276.03 296.26 1.37 25.59 26.00 36.44 35.62 
29 M -2 42.5 44.5 282.05 297.81 1.32 42.51 39.00 58.60 51.48 
30 F 1 45.5 44.5 264.85 326.53 1.43 20.79 19.00 29.05 27.17 
31 F 2.5 47 44.5 306.76 336.28 1.23 40.55 35.00 49.14 43.05 
32 M 0 45 45 276.59 297.81 1.37 36.02 32.00 49.21 43.84 
33 M 0 45 45 276.59 297.81 1.37 36.02 32.00 49.21 43.84 
34 F 3.5 48.5 45 306.89 337.42 1.23 40.83 34.00 49.41 41.82 
35 F 1.5 48 46.5 267.80 291.40 1.43 35.81 31.00 49.31 44.33 
36 F -0.5 47 47.5 295.37 333.65 1.28 36.47 37.00 47.14 47.36 
37 F 2 49.5 47.5 296.51 374.06 1.28 22.11 22.00 28.69 28.16 
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38 M -2 47 49 275.87 306.99 1.37 36.18 34.00 48.93 46.58 
39 M 1 50 49 271.62 309.13 1.37 35.65 33.00 49.59 45.21 
40 M -5.5 43.5 49 290.19 317.92 1.28 37.90 35.00 49.56 44.80 
41 M -5.5 43.5 49 291.48 317.92 1.28 37.90 35.00 49.36 44.80 
42 M -2 47 49 295.09 453.91 1.28 23.00 23.00 29.53 29.44 
43 M -2 47 49 295.09 455.87 1.28 23.14 24.00 29.71 30.72 
44 M -6 44 50 262.67 268.34 1.43 34.94 30.00 50.23 42.90 
45 M -0.5 51 51.5 312.61 410.55 1.19 41.98 45.00 52.28 53.55 
46 M -0.5 51 51.5 312.61 410.55 1.19 41.98 45.00 52.28 53.55 
47 M -1 52.5 53.5 296.56 349.48 1.28 37.42 38.00 49.50 48.64 
48 M -1 52.5 53.5 296.56 406.91 1.28 24.28 25.00 32.11 32.00 
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